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Cyclodextrins (CDs) are a series of cyclic oligosaccharides, consisting of 6, 7 
or 8 α-D-glucopyranose units (α-CD, β-CD and γ-CD) linked by α-(1,4) bonds. Their 
topological structures give a hydrophobic interior and a hydrophilic exterior, which 
enable them to form inclusion complexes with many guest molecules. In addition, 
they are biocompatible, do not elicit immune responses and have low toxicity in 
animals and humans. Lignin, one of the major renewable biomass, is a natural 
polymer commonly found in cell walls of wood and annual plants. The objective of 
this research was to develop new non-viral gene vectors based on the CD templates or 
lignin and different cationic polymers, and explore their possible applications for 
gene delivery. 
This thesis is divided into four parts. In the first part, we present a literature 
review of cationic gene delivery vectors for gene therapy. Especially, CD-based 
supramolecular structures and their utilization as building blocks in different delivery 
systems were reviewed to justify the significance of the research work presented in 
this thesis. 
In the second part, we apply hyaluronic acid (HA) to modify β-CD-OEI 
(oligoethylenimine) star polymers as a gene vector to target cluster determinant 44 





used to β-CD-OEI-HA polymers. One reaction is between the carboxyl groups of HA 
and the amine groups of β-CD-OEI, the other one is reductive amination. Both 
procedures are successful to synthesize β-CD-OEI-HA polymers, which show 
enhanced gene transfection efficiency in CD44 positive breast cancer cell (MDA-
MB-231). Since one procedure use the carboxyl groups of HA, which is where HA 
interact with CD44, overmodification will affect HA mediated endocytosis. 
Reductive amination, which does not affect the carboxyl group, is better for the 
following targeted delivery. In addition to deliver reporter gene, we also use β-CD-
OEI-HA polymers to deliver wild-type p53 (protein 53) gene into MDA-MB-231, 
which showed obvious G1 cell cycle arrest compared to those transfected with 
p53mt135 gene.  
In the third part, we developed a α-CD-based supramolecular 
polypseudorotaxane hydrogel system for sustained gene delivery. This design may be 
advantaged on maintaining the long term local availability of pDNA vectors to 
surrounding tissues and the following expression of protein. Methoxy-poly(ethylene 
glycol)-b-poly(ε-caprolactone)-b-poly[2-(dimethylamino)ethyl methacrylate] 
(MPEG-PCL-PDMAEMA) triblock copolymers with well defined cationic block 
length were first prepared to condense pDNA (plasmid DNA) into nanoparticles with 
hydrophilic MPEG in the outer corona, followed by encapsulating these nanoparticles 
in α-CD-based polypseudorotaxane hydrogels. The resultant hydrogels were able to 
sustain release of pDNA up to 6 days. The MPEG corona not only improved the 
stability of pDNA polyplexes, but also served as an anchoring segment in the ultimate 
hydrogels. This supromolecular in situ gelling system may have immense potential as 
an injectable carrier for sustained gene delivery. 
In the final part, we utilize the abundant natural biomass resource of lignin as 
starting material to create functional polymeric materials with great added values. A 





delivery system in an efficient way. In this strategy, lignin was first modified into a 
lignin-based macroinitiator, followed by grafting of cationic PDMAEMA arms onto 
the lignin core via ATRP technique. A series of lignin-PDMAEMA graft copolymers 
with varied composition were synthesized. These copolymers have a hyperbranch-
shaped structure with a hydrophobic core of lignin and multiple cationic hydrophilic 
arms of PDMAEMA. In vitro gene transfection experiment showed that the 
modification degree of lignin-based macroinitiators and the chain length of 
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CHAPTER 1 INTRODUCTION 
1.1 Background Information 
Gene therapy is a potential method to treat certain disorders by replacing or 
altering the defective gene with normal ones, especially those caused by genetic 
anomalies or deficiencies [1]. Although this method has been effectively used in some 
clinical trials [2, 3], it is sobering to consider that gene therapy is far from a standard 
of medical practice. The biggest challenge that scientists face today is efficient 
delivery of therapeutic DNA into target site with minimum toxicity. Generally, there 
have been two approaches for gene delivery. The first approach consists of the use of 
viral vectors, which are highly effective, such as retroviruses [4] and adenoviruses [5].  
However, viruses can cause severe side effects, which include insertional mutagenesis, 
oncogenic effects, unexpected immune responses and inflammatory reactions. The 
death of Jesse Gelsinger, a young volunteer for a gene therapy trial at the University 
of Pennsylvania in1999, has cast a cloud over this approach [6]. 
The second approach involves using non-viral vectors, which are categorized 
into two groups: (1) naked DNA delivery by a physical method, such as gene gun and 
electroporation and (2) delivery mediated by a chemical carrier such as cationic 
polymer and lipid. Physical method appears to be limited to tissues that are easily to 
access and is unsuitable for systematic delivery due to the presence of serum nuclease.  
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All these limitations have led to the fast development of cationic polymers and lipids, 
as they can spontaneously self-assemble with and condense pDNA into structures 
small enough to enter cells via endocytosis and can be shielded from contact with 
DNase [7]. The advantages associated with polycations include low immunogenic 
response, the possibility of selected modifications, the capability to carry large inserts 
and large scale manufacture. While the transfection efficiency of these polycations is 
still lower than that of viral vectors, a great number of adjustments could improve this 
category of carriers which are, thus far, believed to be the most promising delivery 
system [8].  
In cationic polymers, Polyethylenimine (PEI) has a privileged place in the 
components of non-viral gene delivery, due to its superior transfection efficiency both 
in vitro and in vivo [9, 10]. PEI is a versatile polymer that can be synthesized in 
different lengths, be branched or linear, and undergo functionalized group addition or 
substitution. The transfection efficiency of PEI is mainly depended on its molecular 
weight. Although high molecular weight PEIs show high transgene expression, their 
rather high cytotoxicity [11], non-special interaction and aggregation in blood [12] 
strictly limit their application in vivo. On the other hand, low molecular weight PEIs 
are less toxic but their transfection efficiency are also very low[13, 14]. To overcome 
these disadvantages, one common strategy is introducing a biocompatible or 
biodegradable backbone/core to assemble low molecular weight PEIs. Star-shaped 
copolymers, comb-shaped copolymers [15-17] and polymers with grafting low 
molecular weight PEI [18-20] have been developed in the last decade, these polymers 
show low cytotoxicity and high transfection efficiency. 
To develop PEI based non viral vectors, many materials have been 
investigated. Recently, the surface modification of nanoparticles through the 
cyclodextrin based supramolecular chemistry approach has drawn increasing interests. 
CDs are a series of cyclic oligosaccharides composed of 6, 7, or 8 D(+)-glucose units 
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linked by α-1,4-linkages and named α-, β-, or γ-CD, respectively. They are 
biocompatible, and do not elicit immune responses and have low toxicities in animal 
and human bodies [14]. On the other hand, CDs are cup-shaped molecules that have a 
hydrophobic cavity and a hydrophilic exterior, which makes them water soluble and 
able to interact with various hydrophobic guest molecules to form supramolecular 
inclusion complexes. Because of these highly desirable characteristics, CDs have 
been profusely exploited to improve bioavailability of poorly soluble drugs, to 
prevent side effects or to enhance membrane permeability in pharmaceutical industry. 
Davis and coworkers were the first group to introduce CD-based polymers for gene 
delivery [21]. In the last decade, numerous attempts have been reported to utilize the 
benefits of CDs to deliver nucleic acid with various structure, such as cross-linking 
CDs [22-24], CD-pendent polymers [25-27] and polyrotaxanes [18-20]. They showed 
decreased toxicities and enhanced gene transfection efficiency. 
Lignin, one of the major renewable biomass, is a natural polymer commonly 
found in cell walls of wood and annual plants, which together with hemicelluloses 
acts as a cementing matrix of cellulose fibers in the woody structures of plants. Lignin 
is one of the major components of wood and annual plants, making up 24 – 35 % of 
over-dry weight of softwoods and 17 – 25 % of hardwoods. After cellulose, lignin is 
the most abundant natural non-fossil organic carbon source on Earth, and regenerates 
at a rate of 50 billion tons per year [28]. As a main by-product from pulp and paper 
industry, the global output of lignin is over 50 million tons per year. However, more 
than 95% of the output had been disposed or incinerated as wastes [29]. At present, 
research of lignin-based materials is still at very early stage and their applications are 
quite limited.  
One of the biggest challenges for cancer gene therapy is to target a desired 
tissue or cell type. Several surface markers have been identified to be either 
overexpressed or only found in embryonic or highly proliferative tissue. This offers 
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the possibility to achieve increased specificity of particulate gene delivery systems 
when incorporating the corresponding ligands into the carrier system. These ligands 
include tumor specific antibody [30], transferrin [31], growth factor [32], folic acid 
[33], hyaluronic acid [34] and etc. HA  is an acidic mucopolysaccharide distributed 
widely in the extracellular matrix (ECM) and found in the liquid portion of 
mammalian joints [35]. It is a large, linear glycosaminoglycan composed of 2000-
25,000 disaccharides of D-glucuronic acid and D-N-acetylglucosamine, linked 
together via alternating β-1,4 and β-1,3 glycosidic bonds, with molecular weights 
usually ranging from 105 to 107 Da [36, 37]. It has been reported previously that HA 
is one of the few polyanions which can coat DNA/polycation complexes without 
disrupting their structures [35]. HA is a relatively low toxic polymer approved by the 
FDA for injection. Moreover, a receptor for HA, CD44, is known to be over 
expressed on various tumor cell surfaces [38, 39]. As such, HA would work both as a 
protecting coat against blood components and as a ligand for targeted cells. 
Recently, re-establishing of tumor suppressor regulated cellular pathways 
shows prospective outcome of an effective anti-cancer therapy [40]. The p53 protein 
acts as an internal guardian of the genome, and it can induce cell cycle arrest and 
apoptosis in response to carcinogenic signaling [41]. On the other hand, previous 
researches have reported that the p53 gene mutations exist in approximately 50% of 
human cancers [42, 43]. In addition, Fujiwara successfully induced apoptosis by 
using a retroviral vector expressing the wild-type p53 in human lung cancer [44], 
which showed that reinstatement of single gene function was sufficient for cancer cell 
death in spite of multiple genetic disorders in the cancer cell. Therefore, it becomes 
reasonable that restoring p53 function has impact on cancer therapy [5].   
To sum up, it is urgent to develop non viral vectors that can specifically target 
cells or tissues to increase the efficacy of cancer gene therapy. Although many new 
non viral vectors have been reported on targeted gene delivery in last decade, the 
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results are still far away from satisfactory for biomedical application. Very little 
research has been done on modification of CDs based nanoparticles with HA for 
targeted polymeric gene delivery. No lignin-based biomaterials have been reported 
for gene delivery. 
1.2 Objective and Scope of Study 
The objective of this study was to develop new cationic copolymers as gene 
delivery vectors based on low molecular weight PEI, or oligoethylenimine (OEI) and 
poly[2-(dimethylamino)ethyl methacrylate] (PDMAEMA), which were grafted to or 
copolymerized with cyclodextrins, lignin, and other functional blocks that could 
enhance the gene delivery properties and/or lower the cytotoxicity of the gene 
delivery vectors. The specific aims of this study were: 
• To synthesize a CD44 mediated targeted gene delivery carrier by combining 
multiple oligoethylenimine (OEI) arms conjugated β-CD and HA through 
reductive amination for efficiency delivery of wild-type p53 and explore their 
potential for targeted cancer gene therapy. 
• To develop a cyclodextrin-based polypseudorotaxane hydrogel based on α-
CD, PEG, PCL (polycaprolactone) and PDMAEMA for sustained pDNA 
delivery and explore their potential as an injectable carrier for sustained gene 
delivery. 
• To design a novel biomass-based amphiphilic block copolymer based 
on lignin and PDMAEMA for in vitro pDNA delivery and showcase the 
biomedical application of such biomass-based materials.  
This research should provide some new cationic polymers for non viral gene 
delivery and extend their applications to targeted cancer gene therapy by conjugating 
HA. Results of present study may be helpful in the development of safe and efficient 
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delivery system in future cancer gene therapy. 
This thesis mainly focuses on the synthesis and characterization of CDs or 
lignin based copolymers. Their gene transfection ability was analyzed in vitro in cell 
culture systems. 
1.3 Organization of the Thesis  
Encompassing the objectives outlined previously, the detailed research works 
on CDs or lignin based biomaterials and their biomedical applications will be 
reported in the following chapters. Hence, a better comprehension of the original and 
contribution of this study can be achieved. 
Chapter 2: Literature review on the topic of cationic polymer gene delivery system, 
with emphasis on PEI, PDMAEMA, CD-based supramolecular polymers and lignin-
based copolymers. Brief summary of targeted cancer gene therapy was also given by 
reviewing researches that utilize HA and CD44 interaction for reporter gene or 
therapeutic gene delivery. 
Chapter 3: Report on a new non-viral gene delivery system by conjugating HA with 
star-shaped β-CD-OEI. The HA segment in the final copolymer helped to bind 
specifically with CD44, which is overexpressed on the membrane of some breast 
cancer cell lines, and efficiently deliver therapeutic p53 gene into these cells. In 
addition, HA decreases the cytotoxicity of β-CD-OEI to make this system safe.  
Chapter 4: Highlight on the development of CD-based poly-pseudorotaxane hydrogel 
with anchored cationic copolymer/pDNA. This easily prepared in situ gelling system 
was explored as a sustained gene delivery carrier. 
Chapter 5: Exploration on bio-mass based amphiphilic block copolymers (lignin-
PDMAEMA) as a novel vector for pDNA delivery. The effects of the modification 
degree of lignin-based macroinitiators and the chain length of PDMAEMA arms on 
transfection efficiency were investigated. 
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Chapter 6: Conclusion on the work done with possible future endeavors.  
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CHAPTER 2 LITERATURE REVIEW 
2.1 Non-viral Gene Delivery Vectors Based on Cationic 
Polymers 
In the field of gene therapy, the main challenge is to develop effective non-
viral vectors. Synthetic and natural polycations are good candidates because of their 
low immunogenicity, relatively large sequences condensation capability, good 
protection of DNA, easy modification for targeting specific cells or tissues and large 
scale manufacture [1]. The number of cationic polymers utilized is huge, and many of 
them have been fundamentally investigated to get a better understanding of DNA-
polycation interactions, focusing on the importance of polymer structure, serum 
and/or salt stability, pH and charge ration on particle size. In this review, the progress 
made with the most studied polymers will be summarized. As this thesis mainly focus 
on the synthesis and characterization of cationic polymer for gene delivery, a brief 
review on polyplexes and mechanism of the transfection process will be given first.   
2.1.1 Polyplexes and Mechanism of the Transfection Process 
The term polyplexes refers to complexes formed when a cationic polymer is 
mixed with DNA in aqueous solution. Polycation-DNA interaction is mainly driven 
by electrostatic contact between the cationic polymer and phosphate groups, leading 
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to the reversible linear to globule transition of DNA. At a certain charge ratio 
(cationic polymer/DNA), DNA undergoes localized bending or distortion, which 
facilitates the formation of nanoparticles with different shapes, such as rods, toroids 
[2-4] and spheroids [5]. The ability of cationic polymer to condense DNA into 
nanoparticles is critical for successful transfection, since DNA must be protected from 
DNase degradation. As the DNA packed within polyplexes is well protected, the next 
step is to enter the cell. Polyplexes exhibit a net positive charge, which interact non-
specifically with negatively charged glycoproteins, proteoglycans and sulfated 
proteoglycans [6-9] located on the surface of cell membrane, and enter the cell 
predominantly via fluid-phase [10] or adsorptive endocytosis [11] (Figure 2.1). The 
efficacy of cellular uptake can be greatly improved by increasing the net positive 
charge, prolonging the incubation time or raising the polyplex concentration [11-13]. 
Alternative paths of cell internalization include phagocytosis (particle aggregation at 
low charge ratio), and pinocytosis (interaction with caveolae pits [14]), but these two 
paths largely depend on the cell type. 
After internalization, the next crucial step in cationic polymer gene delivery 
is the escape of polyplexes from the endosome. Irrespective of the endocytosis path, 
polyplexes will be captured into endosomal vesicles. Once inside the pH of the 
endosome rapidly decreases to 4, this then triggers the fusion of late endosome with 
lysosome and release a lot of degradative enzymes. The inefficient release of 
polyplexes from endocytic vesicles into the cytoplasm is one of the main causes of 
low transfection efficiency [15] since most DNA retained in the endosome is 
eventually inactivated or degraded by lysosomal enzymes. A number of researches 
have been done in enhancing endosomal release. One involves using fusogenic 
peptides or lipids to disrupt the endosomal membrane [16]. Another strategy is to use 
cationic polymers that have high buffer capacity known as “proton sponge” [17]. This 
theory proposes that cationic polymers containing internal secondary and tertiary 
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amines can effectively resist endosomal acidification through capture and absorption 
of protons. This buffer capacity delays lysosomal fusion to the endosome and enables 
counter ions (Cl- and H2O) to flood the endosomes, restoring the electronic balance 
[18]. The most common polymers known to overcome endosomal degradation 
include polyethylenimine (PEI) [19-21], poly (L-histine) [22-24] and imidazole-
containing polymers [25-27]. 
Following the release from the endosome, the transgene traffics toward the 
nucleus and the nuclear entry of transgene is the ultimate obstacle for successful gene 
delivery. Two main mechanisms have been proposed to explain the nuclear entry 
process: (1) passive entry during cell division when the nuclear membrane 
temporarily disassembles, or (2) active transport through nuclear pore complexes. In 
the last decade, mechanism for the nuclear import of plasmids has been described 
[28-31], and methods to improve delivery efficiency have also been developed 
depending on these mechanisms. Although plasmids are delivered to cells using a 
number of carriers, entry of DNA into cytoplasm is followed by dissociation from the 
delivery vector as only free DNA can be transcribed in the nucleus. This DNA does 
not stay ‘naked’ for long and is quickly combined by a number of cellular proteins. 
Numerous studies have shown that these proteins bind to exogenous DNA and ferry 
DNA to the nucleus by minimal import machinery. These proteins contain relatively 
short sequences known as the “nuclear localization sequence” or “nuclear localization 
signal” (NLS) that are targeted to the nucleus [30]. In recent years, increasing interest 
arises in identifying novel NLS motifs and the import receptors that recognize and 
bind them. Simian Virus 40 (SV40) [32, 33], glucocorticoid (GC) ligands [34, 35] and 
kappa B (NFκB) [36, 37] have been reported as NLS. These results disclosed that 
carriers showing higher ability to enter the nuclear envelope will enhance transfection 
efficiency. After nuclear uptake, the transgene is transcribed into messenger RNA 
(mRNA), which then translated to the desired protein.  
 
























































         
Figure 2.1. General scheme of gene transfer using non-viral vectors. 
A great number of different polymers with linear, branched and dendrimeric 
structure, have been tested, in terms of efficacy and safety for in vitro transfection. 
However, no architecture emerged as a general favorite [38]. Thus, the discovery of 
new potent non-viral vectors still relies on empirical approaches. 
2.1.2 Polyethylenimine Based Gene Delivery Vector 
Polyehtyleneimine (PEI) is a polymer that has been known for a long time 
and has been widely used in water purification, paper production and shampoo 
manufacture. This polymer has been extensively studied as non viral gene carrier 
since Boussif et al. first reported that PEI/DNA complexes can successfully transfer 
genes to many eukaryotic cell lines [39]. A most important feature of PEI is its high 
cationic charge density because every third atom is a potentially protonable amino 
nitrogen, which makes the polymeric network an effective “proton sponge” at 
virtually any pH; hence, once PEI-based polyplexes enter the endosome, they can 
absorb the protons in this organelle, resulting polymer swelling because of repulsion 
between protonated amine groups. In addition, an influx of Cl- ions happens to 
prevent the build-up of a charge gradient. Polymer swelling and osmotic swelling of 
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the endosome triggers destabilization of the endosome and release its content into the 
cytoplasm [18]. Therefore PEI is regarded as the gold standard for polymer-based 
gene carriers because of its excellent transfection efficiency in both in vitro and in 
vivo models [40]. Depending on the linkage of the repeating ethylenimine units, PEI 
is available in two main forms: linear and branched. 
2.1.2.1 Branched PEI (bPEI) 
bPEI is synthesized by acid catalyzed polymerization of aziridine monomers, 
resulting in random branched polymers (Figure 2.2). The efficacy and cytotoxicity of 
bPEI-derived non viral vectors largely depend on material characteristics such as 
molecular weight, degree of branching, cationic charge density and buffer capacity 
[41-43], polyplex properties, like zeta potential, particle size and DNA content; and 
experimental conditions such as incubation time, presence or absence of serum during 
transfection and polyplex concentration.  
High molecular weight bPEI, 25 kDa and 800 kDa, has been used as gene 
carrier, they exhibit perfect condensation capability and increased transfection 
efficiency, compared to lower molecular weight PEI [44]. However, at the same time 
the cell viability decreased dramatically [45,46]. The cytotoxicity correlate with the 
molecular weight and intracellular concentration of PEI [47] and increase with a 
prolonged incubation time. In vivo experiments showed that bPEI (25 kDa) activated 
genes involved in the Th1/Th2 immune response and FasL-mediated antigen-induced 
cell death [48]. Gharwan and Wightman also reported that systemic administration of 
bPEI (800 kDa) had a lethal effect in animal models [49,50]. These results 
demonstrated the need of materials allowing for the design of less harmful but 
effective PEI based vectors.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
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Figure 2.2. Synthesis of branched polyethylenimine by acid catalyzed 
polymerization of aziridine in aqueous solution. 
2.1.2.2 Linear PEI (lPEI) 
lPEI is synthesized via cationic ring-opening polymerization of either N(2-
tetrahydropyranyl)azidirine or unsubstituted and two-substituted 2-oxazolines 
followed by acid or base-catalyzed hydrolysis of the corresponding N-substituted 
































































Figure 2.3. Synthesis procedures of linear polyethylenimine. 
 
While bPEI/DNA polyplexes remained a rather small size (about 100 -600 
nm), which only slightly changes according to the medium applied, lPEI mixed with 
pDNA forms rather large particles ( >1000 nm) in salt-containing buffers, which are 
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easy to aggregation because of the weakened repulsion between the positive charged 
particles [42,50]. It has been reported that lPEI with 22 kDa, e.g. ExGenTM 500, 
displayed excellent transfection efficiency with a rather low cytotoxicity [50,52,53]. 
One reason is that large particles sediment onto cells more quickly than small ones 
due to their different Brownian molecular motion, resulting in an increase of particle 
uptake in vitro [54,55]. On the other hand, large particles exhibit a higher intrinsic 
endolysosomal activity, which may facilitate their escape from the acidic 
compartment [55]. However most studies have been limited to only a few 
commercially available lPEI derivatives, even these derivatives show cytotoxic effect 
at a certain dose. To circumvent these disadvantages, one effective approach is to 
crosslink low molecular weight PEIs to form high molecular weight conjugates. For 
example, Thomas et al. reported that cross-linking enhanced the transfection 
efficiency of low molecular weight PEIs by 40- to 550- fold in vitro, and the 
efficiency of the most potent conjugates even exceeded that of bPEI (25 kDa) [56]. In 
vivo experiments showed that cross-linked PEIs were 17 to 80 times more effective 
than unmodified ones. Another common strategy is introducing a biocompatible or 
biodegradable backbone/core to assemble low molecular weight PEIs. Generally 
speaking, combination of PEI with either natural or biocompatible synthetic polymers 
generates new polymer with lower cytotoxicity and good biodegradability. Star-
shaped copolymers (Figure 2.4A) [57,58], comb-shaped copolymers (Figure 2.4B) 
[59-61] and polymers with grafting low molecular weight PEI (Figure 2.4C) [62-64] 
have been developed in the last decade, these polymers show low cytotoxicity and 
high transfection efficiency.  
 





































































































Figure 2.4. Chemical structures of representative PEI derivatives. 
 
2.1.3 Poly(2-N,N-dimethylaminoethyl methacrylate) (PDMAEMA) Based 
Gene Delivery Vector 
Although PEI is the most popular non viral DNA carrier, a great number of 
other synthetic polymers have also been explored, such as PDMAEMA and its 
deratives. The structure of PDMAEMA is shown in Figure 2.5. PDMAEMA has 
shown great potential in developing ideal non viral vectors because of its versatile 
synthesis strategies through atom transfer radical polymerization (ATRP) or 
reversible addition fragmentation chain transfer (RAFT) polymerization methods. 
Cheng et al. first applied PDMAEMA for gene delivery in 1996 [65]. They reported 
that PDMAEMA with a molecular weight of 360,000 g/mol showed optimal 
transfection efficiency at weight ratio of 3 to 5, and the cell viability of optimized 
polyplexes was around 80%. Later, the same group published two more extended 
studies in which PDMAEMA with varying molecular weights (4,000 - 817,000 g/mol) 
were compared [66,67]. They concluded that the molecular weight of PDMAEMA 
significantly influenced transfection efficiency, and higher molecular weights (> 
300,000 g/mol) showed higher transfection efficiencies. The authors associated the 
molecular weight dependence with polyplex size. Recently, Layman also 
demonstrated that with the increasing of molecular weight, the transfection efficiency 
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of PDMAEMA escalates [68]. However, many barriers must to be circumvented to 
make this polymer a good carrier. For example, it was shown that PDMAEMA did 
not physically disrupt late endosomes/lysosomes to empty their contents to the 
cytosol [69]. Confocal laser scanning microscopy also revealed that a major part of 
the PDMAEMA/pDNA polyplexes was still present in endosomes even after 24 hours 
of incubation [70,71]. Cytotoxicity and non-specific interactions must be reduced to 













Figure 2.5. Chemical structure of PDMAEMA. 
2.1.3.1 PEGylation 
Many researches have been done in reducing the toxicity of PDMAEMA 
while maintaining its high transfection efficiency and PEGylation is the predominant 
strategy, in which PEGylated components are used to sterically shield the cationic 
carriers from interaction with blood components. It is well documented that the steric 
stabilization provided by PEGylation reduces particle aggregation in serum and 
extends circulation lifetime [73-75]. It is typically assumed that the extended 
circulation lifetime can be attributed to the reduction or prevention of serum protein 
adsorption [76]. PEG has been applied to the surfaces of polyplexes by covalently 
coupling to polymers either before polyplex formation (pre-PEGylation) [77] or after 
polyplex formation (post-PEGylation) [78]. By PEGylation, reduced cytotoxicity and 
controlled biodistribution were achieved, while poor endosomal escape and 
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intracellular trafficking of cellular uptake arises. The surface aqueous phase formed 
by the PEG moiety inhibits the interaction of the gene carrier with cell surface, which 
results in poor cellular uptake. Moreover, the enhanced stability of polyplexes, 
coming from PEGylation, leads to poor endosomal escape via membrane fusion and 
in well degradation of cargos in lysosomes, digestive compartments [79,80]. These 
serious issues regarding the use of PEG in gene delivery for cancer are referred to as 
the ‘PEG dilemma’. 
Three strategies have been proposed to overcome the ‘PEG dilemma’ [81]. 
The first approach is to conjugate ligand that specifically binds with the receptors on 
the membrane of targeted cells. Folate receptor (FR) is a glycosylphosphatidylinositol 
(GPI)-linked membrane glycoprotein with a molecular weight of 38 - 40 kDa [82],  
which is known to be over-expressed in many human cancers and its distribution in 
normal tissues is minimal [83,84]. Therefore, folate-targeting gene delivery system 
has been extensively studied. Intraperitoneal administration of folic acid (FA) 
modified pDMAEMA/pLuc polyplexes yielded about 10-fold lower luciferase 
transfection levels in organs lined by the mesenthelial layer without compromising 
the degree of tumor cell transfection [85]. Zhou et al. also showed that FA-terminated 
polyrotaxane-PEI600 exhibited a lower cytotoxicity, strong specificity to FR, and 
high efficiency of delivering DNA to target cells in vitro and in vivo [86]. Other 
frequently used ligands include Transferrin (Tf), arginine–glycine–aspartic acid 
(RGD), integrin, peptide and antibody. 
The second approach is cleavage of PEG from the carrier system. 
Intracellular microenvironments, such as low pH of endosome/lysosome and reducing 
environment in the cytoplasm, are employed as triggers of PEG cleavage. Walker et al. 
reported that pH-sensitive polyplexes with pH-labile hydrazone linkages between 
PEG and polycation showed significantly higher gene expression both in vitro and in 
vivo [87]. Other linkages such as vinyl esters [88], orthoesters [89] or acetyls [90] 
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have also been employed as a pH-sensitive PEG system in lipoplexes or polyplexes. 
In addition to the pH gradient, the intracellular reducing environment generated by 
small thiolytical molecules is regarded as another stimulation trigger. PEG-lipid 
linked with disulphide bonds synthesized by Zaliphsky and colleagues showed an 
increased rate of release of anti-cancer drugs from liposomes compared with stable 
PEG-lipid modified liposomes [91]. Recently, tumor specific cleavage of PEG has 
been proposed for cancer gene therapy. Matrix metalloproteinase (MMP) is massively 
up-regulated in malignant tumors, and is involved in angiogenesis, invasion and 
metastasis due to its unique ability to degrade the ECM [92]. Hatakeyama et al. 
demonstrated that i.v. administration of a PEG-peptide-lipid ternary conjugate, which 
can be cleaved by MMP, resulted in enhanced pDNA expression in tumor tissue, as 
compared with conventional PEG-lipid [93].  
The third strategy to increase the endosomal escape of PEGylated gene 
carriers is the disruption of endosomal membrane or acceleration of membrane fusion. 
Fusogenic membrane peptides, such as GALA [94] and KALA [95], have been used 
in PEGylated lipoplexes or polyplexes to improve their gene transfection efficiency 
due to an accelerated endosomal release of the cargo.  
2.1.3.2 PDMAEMA Based Copolymers as Gene Carriers 
In an attempt to increase the transfection efficiency and reduce the 
cytotoxicity of PDMAEMA, a series of DMAEMA-based copolylmers using MMA, 
PEGMA or NVP as comonomers were synthesized by van de Wetering et al [66,96]. 
When the molecular weight of the above DMAEMA-based copolylmers is around 
100 000 g/mol, the transfection efficiency and toxicity of NVP(14 mol-%) and 
PEGMA (21 mol-%) containing copolymers were similar to those of PDMAEMA 
homopolymer, while a copolymer containing MMA (20 mol-%) showed comparable 
transfection efficiency at lower w/w ratios. However, higher molecular weight (> 170 
kDa) copolymers exhibited reduced transfectivity in comparison with the 
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homoplymer due to the reduced capability to condense the size of the plasmid. 
In addition to the above mentioned random copolymers, some research 
groups have focused on the development of cationic block copolymers for gene 
delivery. The aim of this approach is to develop polymer/DNA complexes which 
possess a hydrophilic corona acting as a steric stabilizing layer and preventing 
aggregation of the formed polyplexes [97]. Diblock copolymers, such as DMAEMA-
block-2-(methacryloyloxyethyl phosphorylcholine) (DMAEMA-MPC) [98] and 
DMAEMA-block-(N-(3-(methacryloylamino) propyl)-N,N-dimethyl-N-(3-
sulfopropyl) ammonium hydroxide) (PDMAEMA-b-PMPDSAH) [99], have been 
investigated. While DMAEMA-MPC copolymer/DNA complexes showed 
significantly lower transfection efficiency than DMAEMA homopolymer, 
PDMAEMA-PMPDSAH results in 4-5 folds more effective than PEI (25 kDa) in the 
presence of high serum concentration. Possible reason is that MPC block profoundly 
obstructed the cellular internalization of nanocomplexes, while incorporation of 
polysulfobetaine remained the increased cellular uptake. Cheng et al. synthesized a 
series of DMAEMA-PEGMA-(DEAEMA-BMA) triblock copolymers to enhance the 
intracellular delivery of mRNA [100], in which the DMAEMA segment was used for 
mRNA condensation, PEGMA segment for stability and biocompatibility, and 
DEAEMA-BMA segment for cytosolic entry. Transfected DC2.4 cells with the above 
triblock copolymer were able to activate antigen-specific T cells.  
2.2 Targeted Gene Delivery 
   It is necessary to address gene delivery vectors to specific cell types in 
order to minimize off-target effect. Targeting can be achieved by incorporating 
structures which facilitate the exclusive uptake in certain tissues or cell types. Folate, 
transferring, HA and antibody have frequently been introduced as targeting moiety in 
cationic polymer gene delivery systems in the last decade. In this literature review, we 
will focus on HA. 
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2.2.1 Potential of Hyaluronic Acid as Tumor Targeting 
   HA, also called hyaluronan, is a natural linear polysaccharide that have 
pivotal roles in various biological functions, such as stabilizing and organizing the 
ECM, regulating cell adhesion, motility, mediating cell proliferation and 
differentiation [101,102]. More than 50% of HA in the body is present in skin, lung, 
intestine, and ECM [103]. Currently, HA is commercially produced from animal 
tissues such as cock’s comb and from fermented microorganism. The fact, that HA 
molecules from different sources have the same primary structure, explains the 
molecular basis for its natural biocompatibility [103]. The amount of HA in a tissue 
depends upon a complex interplay among HA synthesis by HA synthases [104], HA 
internalization by cell surface receptors [105] and extra-cellular degradation by 
hyaluronidases [106]. Owing to its biocompatibility and biodegradability, HA has 
been extensively investigated for biomedical applications such as tissue engineering 
[107], drug delivery [108], and molecular imagin [109]. In particular, HA acts 
through CD44, its principal receptor, and RHAMM (receptor for HA mediated 
motility) to regulate cell proliferation and movement. Many of the downstream 
pathways following CD44 activation become down-regulated in cancer, leading to 
tumor growth, progression and metastasis [110]. Furthermore, the cancer stem cell 
theory has recently proposed that CD44 represents a marker of breast cancer stem 
cells [111]. The relationship between tumor cells and hyaluronic acid receptors 
indicates that it may be possible to recruit hyaluronic acid for active targeting to 
tumor cells bearing this receptor. 
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Figure 2.6. HA structure: polymeric repeat of D-glucuronic acid and N-
acetylglucosamine. The asterisk (*) represents potential sites of chemical 
conjugation.  
The discovery that many cancer cells over-express CD44 led to the fast 
development of HA-drug conjugates [112] and HA-modified particulate drug carrier 
systems [113] that were able to target these tumor cells very specifically in vitro and 
in vivo. HA have multiple functional groups available for chemical conjugation 
(Figure 2.6). The earliest reports of an HA-drug conjugate designed to specifically 
target over-expressed CD44 were performed by Akima et al., who showed uptake of a 
fluorescent HA conjugate in Lewis lung carcinoma cells [114]. More importantly, this 
HA-drug conjugate decreased cancer progression in several models of cancer. HA-
drug conjugates have also been used to deliver drugs with physical properties that 
limit dosing. For instance, paclitaxel, a well-known anti-mitotic chemotherapeutic 
agent, has low aqueous solubility. Conjugation of paclitaxel to LMW-HA increases 
drug solubility, cellular uptake and cytotoxicity when incubated with cells that 
expressed CD44 in vitro, while CD44 negative control fibroblasts tolerated a much 
higher dose of conjugate drug [115]. Uptake of the above conjugate was CD44 
specific, since it would be blocked by both excess HA and anti-CD44 antibodies. 
HMW-HA has also been explored for targeted drug delivery. Coradini et al. showed 
that HMW-HA conjugated butyric acid, a histone deacetylase inhibitor, increased cell 
apoptosis, inhibited cell growth in vitro and decreased tumor burden in vivo [116]. 
Various forms of HA in drug delivery systems have extensively been investigated in 
the last ten years, such as microspheres [117], hydrogels [118], polymer conjugate 
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[119], dry powder [120] and implants [121]. Superiorities of HA for drug delivery 
includes active drug internalization, reversal of drug resistance, protection of normal 
tissues, and reduced gastrointestinal tract toxicity and cardiotoxicity.  
Unlike HA-drug delivery, the development of HA modified gene delivery 
system is relatively late and slow. Microsphere [117], nanogels or hydrogels [122] 
and nanoparticles [123] using HA as main component are proved to be effective in 
targeted delivery and controlled release of DNA and siRNA to tumor cells that 
express CD44 in vitro. While the use of cationic polymers modified HA for gene 
delivery is rather limited. Possible reasons are its relative high molecular weight and 
negative charges. Ito et al. have recently described the use of hyaluronan and its 
amphoteric derivative spermine-hyaluronan for the coating of DNA/PEI polyplexes, 
which results in an increased transfection efficiency in Chinese hamster ovary (CHO) 
cells [124]. Hornof et al. also showed that coating of purified DNA/PEI polyplexes 
with low molecular weight hyaluronan (<10 KDa) facilitated receptor-mediated 
uptake via the CD44 receptor in HCE cells, increased complex stability in vitro and 
efficiently shielded the positive surface charges of the polyplexes without decreasing 
its transfection efficiency [125]. Although HA modification of PEI/DNA polyplexes 
is effective, a delivery system that contains HA as targeting moiety and also has the 
ability to condense DNA is more convenient for gene therapy. Recently, Jiang et al. 
developed HA modified PEI as a target specific intracellular delivery carrier for 
siRNA. This siRNA/PEI-HA complex exhibited higher gene silencing efficiency in 
B16F1 cells than siRNA/PEI complex. Furthermore, intra-tumoral injection of anti-
VEGF siRNA/PEI-HA complex effectively inhibited tumor growth in C57BL/6 mice 
[126]. High molecular weight HA are also been used for targeted gene delivery. 
Surace et al. synthesized lipoplexes containing HA modified DOPE 
(dioleoylphosphatidylethanolamine) to target the CD44 receptor on breast cancer 
cells [127]. 
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2.2.2 CD44 in Cancer 
   CD44 defines a family of surface glycoproteins involved in cell migration 
and adhesion to extracellular matrices. It is encoded by a single, highly conserved 
gene located on chromosome 11 in humans and chromosome 2 in mice [128]. CD44 
comes in a wide variety of different molecular weight forms, ranging from 80 to 200 
kDa in size. The heterogeneity of this group is attributed to posttranscriptional 
regulation, including alternative splicing and protein modification [129]. Since the 
first report that expressing a variant isoform of CD44 (CD44v) induced a metastatic 
phenotype in locally growing tumor cells [130], CD44 has received considerable 
interests. There is now abundant evidence on the role of CD44 expression in the 
progression of many tumor types [131], as well as in cancer-initiating cells [132]. 
Martine and coworker examined a panel of breast cancer cell lines with their 
expression of CD44 and found that the cell lines expressing the most CD44 were also 
the most invasive [133]. Similar trend was also observed in both in situ and invasive 
breast carcinoma cases, where CD44 was extensively expressed [134].  
2.2.3 p53 Signaling Pathway in Cancer 
   p53 is an intensively studied protein because of its clear role as a tumor 
suppressor both in humans and other mammals. Loss or mutation of p53 is strongly 
associated with an increased susceptibility of cancer [135-137]. p53 is a multi-faceted 
tetrameric transcription factor that transactivates a broad spectrum of genes involved 
in cell cycle progression, cell death signaling, metabolism, DNA repair and 
angiogenesis (Figure 2.7). Moreover, p53 is inactivated in nearly 50% of human 
cancers, and components of the p53 signaling pathway, such as Mdm2 and p14Arf, 
are often misappropriated in the other 50% of cases. In addition, molecular 
epidemiological analyses showed that in several cancer, including breast, head and 
neck, liver and hematopoietic malignancies, a significant association of p53 mutations 
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with worsened patient survival was found [138]. Re-establishing p53 function has 
shown anti-cancer effect both in vitro and in vivo [139-141]. As a result, restoring p53 







Figure 2.7. Activation and function of p53. p53 has a key role in integrating the 
cellular responses (pink boxes) to different types of stresses (blue boxes). 
2.3 Cyclodextrins and Cyclodextrin-based Gene Delivery 
Systems 
2.3.1 Cyclodextrins 
 CDs are natural cyclic oligosaccharides composed of α-1,4-linked 6,7 and 8 
D(+)-glucose units and named with α-, β-, and γ-CD, respectively (Figure 2.8). They 
feature a basket-shaped topology in which glucose hydroxyls orient to the outer space 
flanking the upper and lower rims, while methinic protons point to the inner cavity 
[142]. Such structure imparts a hydrophobic inner cavity with a depth of ca. 7.0 Å and 
an internal diameter ca. 4.5, 7.0 and 8.5 Å for α-, β-, and γ-CD, respectively [143]. 
The ‘inner-outer’ amphiphilic character endows CDs with molecular inclusion 
capabilities, which has been extensively used to improve bioavailability of poorly 
soluble drugs, to prevent side effects or to enhance membrane permeability in 
pharmaceutical industry [143,144]. Their application in the field of non-viral gene 
delivery is relatively late, from formulation excipients to CD-containing polymers. 
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Figure 2.8. Chemical structure of cyclodextrins with cavity and height profile. 
2.3.2 Cyclodextrin-based Polymers 
Depending on the location of CD in the polymer network, CD-based polymer 
is divided into two groups: CD-embedding polymer (CD located in the backbone) and 
CD-pendant polymer (pre-existing gene vector grafted with CD derivatives). 
2.3.2.1 CD-embedding Polymers 
Davis and coworkers were the first group to introduce CD-based polymers 
for gene delivery [145]. The β-CD polymers (Figure 2.9) were able to condense 
pDNA (～5 kbp) into particles of approximately 100-150 nm, and transfect cultured 
cells with an efficiency comparable to PEI and Lipofectamine. Later, the same group 
investigated the structure effects of CD-based polymers on gene delivery capability 
by evaluating CD size (β- or γ-CD) [146,147], distribution and nature of cationic 
elements (their linkages, distances and relative disposition) [147-149], and polymer 
size and polydispersity [146]. Finally, they concluded that the optimal structures, in 
terms of both high transfection efficiency and low cytoxicity, were low molecular 
weight polymers (ca. 10 kDa, degree of polymerization, 5-8) with CD sufficiently 
spaced from amidine cationic centers [150]. More recently, Srinivasachari et al. used 
Cu (I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition [151] of a diazido β-CD 
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derivative and α,ω-dipropargylated oligoethyleneimines(OEI) to get linear CD-
containing polymers for gene delivery. The gene delivery efficiency of the resulting 
polymers were mostly depend on the OEI/CD ratio, the longer the OEI segments, the 
better the transfectivity [152].  
Very recently, through the reaction with carbonyl diimidazole (CDI), the 
group of Yu and Wang crosslinked hydroxypropyl CDs (HPCDs) and short OEI 
chains (OEI600) by reaction with carbonyl diimidazole (CDI) [153]. The resulting 
polymers (Figure 2.10) showed high gene delivery efficiency in SKOV-3 cells, which 
is comparable to that of bPEI (25 kDa). The size of CD (α, β or γ) slightly affects the 
transfection efficiency, with α-CD showing the highest (5.5 fold higher than PEI 25 
kDa) [154]. Tang et al. further grafted HPβCD-OEI600 polymers to folic acid, a 
ligand for FA receptor which is over-expressed in many tumor cells, to achieve 
targeted delivery to several tumor cells [155]. In vivo experiment of HPγCD-OEI600 
polymers grafted to peptide ligands of the human epidermal growth factor receptor 
showed significantly enhanced anti-tumor effects on tumor bearing mice as compared 
to non-targeted HPγCD-OEI600 polymers [156]. 
 












































































































Figure 2.9. Synthesis of CD-containing cationic polymers (CDPs). 
Considering the CD inclusion capability, many researchers make efforts on 
developing supramolecular polymer by inclusion complex interaction before or after 
polyplexes formation. Amiel et al. used a neutral epichlorohydrin-cross-linked βCD 
polymer and cationic compounds with a structural motif having high affinity for the 
βCD cavity (e.g. positively charged adamantane or cholesterol derivatives; Figure 
2.11) [157,158]. The authors demonstrated that by adjusting the proporation of 
cationic guest, the charge density of above polymer can be finely tailored, which 
offers the possibility to control the DNA condensation capability. The ternary βCD 
polymer-adamantyl cationic guest DNA formulations were evaluated for reporter 
gene delivery, with Ada4 vector performing the best and compared well with 
DOTAP-based lipoplexes [159]. On the other hand, Davis and coworkers tried to coat 
preformed polyCDplexes with functional components that improve stability and 
targeting capabilities. For example, the inclusion of adamantane moiety of Ad-PEG 
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into βCD cavities of polyCDplexes prevented aggregation and non-specific 
interactions with serum components [80]. Furthermore, polyCDplexes coated with 
transferrin-modified Ad-PEG showed better transfection efficiency than non-targeted 
particles in vitro [160]. These transferring targeted gene vectors have also shown 
good transfection efficiency and selectivity in different tumor models [161,162]. 
 






































Figure 2.11. Schematic representation of cationic poly-β-CD/DNA polyplexes. 
2.3.2.2 CD-pendant Polymers 
There are some good cationic polymers reported before the first attempt of 
using CDs in gene delivery system, therefore a lot of concern has been drawn on 
attaching CDs to these polymers, such as PEI, poly-L-lysine (PLL) and chitosan. A 
series of CD-grafted PEI polymers were synthesized by reacting controlled 
proportions of 6-mono-tosyl-βCD with bPEI or lPEI [163]. It demonstrated that CD 
grafting significantly decreased the transfection efficiency and toxicity of PEI. 
However, the addition of Ad-PEG obviously increased nanoparticle stability in 
culture media and recovered much of the transfectivity [163]. As mentioned 
previously, this system is also very easy to be decorated with targeting ligands. Pun et 
al. developed a system that could release particles in a controlled manner by 
supramolecular interaction between adamantine-functionalized surfaces with βCD 
grafted PEI-DNA polyplexes (Figure 2.12C) [164]. Based on similar concept, core-
 
Chapter 2: Literature Review 
33 
shell nanoparticles formulated by βCD grafted PEI-PBLA (β-benzyl-L-aspartate) 
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Figure 2.12. Schematic structures of CD-pendant polymers. 
PLL was used very frequently as non-viral vector because of its peptide 
structure and biodegradability. However, it exhibits modest to high toxicity. A 
sunflower-shaped βCD-grafted PLL polyplex was synthesized by Choi et al (Figure 
2.12A) [166]. The authors confirmed that βCD moieties covering the outer layer of 
the polyplex may promote cell attachment and endosomal release through a 
membrane-disrupting mechanism. Chitosan is biodegradable linear 
aminopolysaccharide with randomly distributed β(1→4)-linked glucosamine units. It 
is non-toxic, but its gene delivery efficiency is very low [167]. Therefore, great 
concern has been drawn on improving it. Liu and coworkers evaluated the DNA 
condensation capabilities of βCD-grafted chitosan polymers in the presence and 
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absence of hydrophobic components [168]. They observed that the addition of 
hydrophobic components considerably enhanced the DNA condensation capability of 
βCD-grafted chitosan. More recently, Ping et al. reported the successful delivery of 
pDNA and siRNA using chitosan-graft-(PEI-βCD) (Figure 2.12B) [60].  
2.3.3 Cyclodextrin-based Polyrotaxanes  
Rotaxane is a type of mechanically interlocked system where a cyclic 
molecule is threaded onto an “axle” molecule and end-capped by bulky groups at the 
terminal of the ‘axle’. Polyrotaxanes and polypseudorotaxanes are polymers with 
multiple cyclic molecules threaded by a polymer chain with or without bulky end 
caps. Because of its cyclic structure, CDs have played a major role in this field [169]. 
A lot of researches have been done in this area and some of the most sophisticated 
systems have been applied for gene delivery [143,170,171]. The first example of 
using polyrotaxane in gene delivery was carried out by Shuai et al., in which α-CD 
was threaded onto the polymer chain (bPEI-PCL-PEG) [172]. The high affinity of 
PCL with α-CD cavity recovers polymer solubility and DNA condensation capability, 
resulting comparable transfection efficiency to bPEI but with much lower toxicity.  
Recently, Li and coworkers developed a novel system composed of multiple 
OEI-grafted βCD threaded on a pluronic PEG-PPG-PEG triblock copolymer chain 
(Figure 2.13) [62]. The authors claimed that the high stability of PPG-βCD [173] 
limit the number of βCD units threaded on PEG-PPG-PEG chain, providing free 
mobility of βCD units and thereby facilitating OEI-pDNA interactions. As a result, 
the cationic supramolecular gene delivery vectors showed good DNA binding ability, 
low toxicity, and high transfection efficiency that is similar to bPEI (25 kDa) in 
HEK293 cells, with the longest OEI branches behaved the best. Driven by these 
results, the authors synthesized a series of polyrotaxanes from α-CD and random 
PEG-PPG copolymer to investigate the effect of structure on gene expression [63]. 
They found that α-CD-OEI/PEG-PPG system yielded smaller particles due to the 
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increased mobility of α-CD-OEI, exhibited much less cytotoxicity than bPEI (25 
kDa), and displayed high transfection efficiency in a variety of cell lines including 
COS-7, BHK21, SKOV-3, HEK293 and MES-SA cells. Later, the same group 
synthesized another two series of polyrotaxanes consisting of α-CD-OEI and PEG 
[174] or PPG-PEG-PPG [175] Though no significantly enhanced transfection 
efficiency was observed, α-CD-OEI/PEG polyrotaxanes displayed the same in the 
presence or absence of serum. 
As mentioned in 2.1.1, endosomal/lysosomal escape of polyplex is one of the 
main obstacles for successful gene delivery. Considering this issue, the introduction 
of biodegradable moieties into polycations to dissociate the polyplex becomes an 
interesting topic recently [176]. Yui and cowokers exploited both CD mobility and 
polyrotaxane dissociation to develop a biocleavable system by threading DMAEC-α-
CD (dimethylaminoethylcarbamoil-grafted α-CD) onto PEG chains that were capped 
with Z-L-Phe via disulfide bonds (Figure 2.13) [177]. Intracellular trafficking of 
DMAEC-SS-PRX polyplexes showed rapidly endosomal escape in comparison with 
lPEI (22 kDa) and selective localization of pDNA inside the nucleus after 90 min. In 
addition, by varying the number of CD units threaded and the extent of DMAEC 
grafting, the authors can optimize their pDNA condensing and releasing capabilities 
[178]. Except for α and βCD, γ-CD has also been used for polyrotaxane. LPEI/γ-CD-
based polypseudorotaxanes were synthesized by Yamashita et al. and showed 
improved cellular uptake and lower cytotoxicity [179]. 
 
































































































































Figure 2.13. Schematic structures of CD-based polyrotaxanes. 
2.3.4 Cyclodextrin-centred Star-shaped Polymers  
The development of CDs centered cores for installation of functional 
elements has provided good methods in investigating the multivalent interactions in 
biological recognition processes [180]. As a result, synthesis of cationic polymers 
using this strategy received much attention recently. A series of low molecular weight 
OEI-grafted αCD was synthesized by biodegradable carbamate linkages [58]. (Figure 
2.14) The size of OEI, branching of OEI and the extent of CD grafting were adjusted 
to explore their influences on cytotoxicity and gene delivery efficiency. OEI-αCD 
conjugates (with branched 14-mer OEI) showed the best in terms of transfection 
efficiency, which was comparable to or even higher than that of bPEI (25 kDa).  
Subsequently, βCD-centred star-shaped dendripolymers were developed by 
sequential radical polymerization with DMAEMA and oligoethyleneglycol 
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metacrylate (Figure 2.14) [181]. These cationic polymers can compact pDNA into 
100-200 nm particles with positive zeta potentials of 25-40 mv at N/P ratio of 10 and 

















































































































Figure 2.14. Schematic structures of CD-based star polymers. 
A more efficient strategy to functionalize all (21) positions of βCD was 
reported to generate homogeneous product [182], then a set of different cationic 
methacrylate building blocks were used to modify the 21-armed βCD-centred 
dendripolymers [183]. They found that polymers bearing 
poly(dimethylaminopropylamine) head group showed highest transfection efficiency 
with much less toxicity in comparison with PEI.  
2.3.5 Cyclodextrin-based Supramolecular Hydrogels  
Hydrogels have long been attractive in delivering hydrophilic 
macromolecules, such as DNA, as the entrapped vectors provide a high loading 
efficiency and protective environment. They are formed by chemical or physical 
crosslinking of special class of hydrophilic polymers that imbibe a considerable 
amount of water while maintaining their shape. The entrapped DNA vectors are 
released by ionic exchange or degradation of the biopolymer by cell-secreted 
enzymes in the tissue. Hydrogels can maintain the long term local availability of 
 
Chapter 2: Literature Review 
38 
DNA vectors to surrounding tissues and circumvent the need for repeated 
administration [184]. They further allow easy control on the release behavior of an 
encapsulated gene through modulation of hydrogel network compositions [185].  
In the last decade, hydrogel-based local gene delivery has mainly been 
studied through encapsulation of naked DNA during hydrogel formation. Naked DNA 
was successfully incorporated into collagen[186], alginate[187], pluronic-hyaluronic 
acid [188] and PEG fumarate [189]. Although naked DNA showed gene expression 
[186], limitations with low gene transfection efficiency and rapid diffusion of DNA 
motivated the use of DNA polyplexes instead of naked DNA [190-193]. In this 
strategy, pDNA binds electrostatically to cationic functional groups within the 
hydrogel matrix and be released upon hydrogel dissolution or degradation. This 
complexation protects pDNA from degradation by DNase attack, and as the hydrogel 
degrades, the encapsulated pDNA is released and provides a sustained local DNA 






Figure 2.15. Schematic structure of αCD-PEO-PHB-PEO supramolecular 
hydrogel. 
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  Supramolecular hydrogels based on polypseudorotaxane formation between 
CDs and polymers have showed great potential as biomaterials due to their 
thixotropic nature and excellent biocompatibility [143,194]. The first example of this 
hydrogel was carried out between α-CD and high molecular weight PEO, which 
resulted in a sol-gel transition of the α-CD-PEO aqueous solution [195]. Later, a new 
class of injectable drug delivery systems was developed based on PEO-PHB 
(poly[(R)-3-hydroxybutyrate])-PEO and α-CD for controlled drug delivery [196]. 
(Figure 2.15) This hydrogel was found to be thixotropic and reversible. Driven by 
these results, the same group continued to synthesized PEO-PCL/α-CD and PEO-
PPO-PEO/α-CD hydrogels [143]. These studies demonstrated that the incorporation 
of hydrophobic PHB or PCL segments in the guest polymers strengthened the 
resultant hydrogels and afforded much longer sustained controlled release of drugs 
when compared with α-CD/PEO supramolecular hydrogels. 
2.4 Lignin and Lignin-based Copolymers 
As the issues of environmental pollution and resource crisis are gaining more 
and more attentions from the public and scientific community, the reusing of waste 
and the development of renewable resources have become one of the key research 
topics in the world. Lignin, one of the major renewable biomass, is a natural polymer 
commonly found in cell walls of wood and annual plants, which together with 
hemicelluloses acts as a cementing matrix of cellulose fibers in the woody structures 
of plants. Lignin is one of the major components of wood and annual plants, making 
up 24 – 35 % of over-dry weight of softwoods and 17 – 25 % of hardwoods. After 
cellulose, lignin is the most abundant natural non-fossil organic carbon source on 
Earth, and regenerates at a rate of 50 billion tons per year [197].  
2.4.1 Lignin Composition and Structure 
   Lignins are complex racemic aromatic heteropolymers derived mainly from 
three hydroxycinnamyl alcohol monomers differing in their degree of methoxylation, 
 
Chapter 2: Literature Review 
40 
p-coumarylM1H, coniferylM1G, and sinapylM1S alcohols. p-hydroxyphenyl H, 
guaiacyl G, and syringyl S phenylpropanoid units are produced respectively by above 
monomers to be incorporated into the lignin polymer via radical coupling reaction, 
which is called lignification The amount and composition of lignins vary among taxa, 
cell types and individual cell wall layers and are influenced by developmental and 
environmental cues (Figure 2.16) [198].  
 
Figure 2.16. An example of lignin structure. 
2.4.2 Lignin Degradation and Utiliztion 
   Microbial degradation of lignin represents a key step for carbon recycling 
in land ecosystems since removal of the lignin barrier enables the subsequent use of 
plant carbohydrates by microorganisms [199,200]. Wood-rotting basidiomycetes, 
collectively referred to as white rot fungi, are the only microbes that have been 
convincingly shown to efficiently depolymerize, degrade, and mineralize all 
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components of plant cell walls including cellulose, hemicellulose, and the more 
recalcitrant lignin [199]. 
2.4.3 Lignin-based Copolymers 
   As a main by-product from pulp and paper industry, the global output of 
lignin is over 50 million tons per year. However, more than 95% of the output had 
been disposed or incinerated as wastes [201]. It is mainly burnt as an energy source 
and as part of a complex chemical recovery system. Very few lignin are utilized for 
value-added products, such as stabilizer for plastics and rubber, due to its complex 
irregular macromolecular properties [202]. However, growing interests has been 
drawn on developing novel lignin-based functional materials. Lignin-based gels have 
been reported recently [202-204]. A copolymer of lignin, starch, acrylamide, and 
acrylic acid (LSAA) was developed by Liu et al. to control the non-point pollution 
resulted from surface runoff [205]. No research is reported in using lignin for gene 
delivery. At present, research of lignin-based materials is still at very early stage and 
their applications are quite limited.  
2.5 Concluding Comments 
The above literature survey indicates that there is still an urgent need for 
efficient and safe non viral gene delivery vectors. Lots of efforts could be taken to 
explore new cationic copolymers based on CD and lignin.   
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CHAPTER 3 HYALURONIC ACID CONJUGATED 
β-CYCLODEXTRIN-OLIGOETHYLENIMINE 
COPOLYMERS FOR CD44-TARGETED GENE 
DELIVERY  
3.1 Introduction  
Cancer is the leading cause of death in the world. Currently, about 25% of 
deaths in the United States are attributed to cancer [1]. In the last two decades, gene 
therapy has been extensively explored and considered as a promising substitute for 
conventional chemotherapy [2]. Recently, re-establishing tumor suppressor regulated 
cellular pathways shows prospective outcome of an effective anti-cancer therapy [3]. 
For example, the p53 protein acts as an internal guardian of the genome, and it can 
induce cell cycle arrest and apoptosis in response to carcinogenic signaling [4]. 
Introducing wild-type p53 into human lung cancer cells using a retroviral vector 
successfully induced apoptosis [5], indicating a sufficiency of restating single gene 
function for cancer cell death in spite of multiple genetic disorder. Considering the 
fact that p53 gene mutations exist in approximately 50% of human cancers [6,7], it is 
reasonable to restore the tumor-suppressive function of wild type p53 as an 
alternative means for cancer therapy [8].  
   Successful gene therapy depends on an efficient and safe delivery system 
that delivers the therapeutic genes to a specific target tissue or organ [9]. Non-viral 
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vectors arises as a promising approach for gene therapy due to their markedly safety 
over viral vectors [10]. Polyethylenimines (PEIs) with linear or branched structure 
have been widely used as gene delivery vector both in vitro and in vivo, due to its 
superior transfection efficiency caused by efficient DNA condensation and proton 
sponge effect [2,11,12]. However, their application in vivo has largely been limited by 
the disadvantages including high cytotoxicity [13], lack of specificity and aggregation 
in blood [14]. To overcome these disadvantages, an alternative strategy is to introduce 
a less toxic and biocompatible or biodegradable backbone/core to assemble low 
molecular weight PEIs. In the last decade, several polymers that were characterized as 
low cytotoxicity and high transfection efficiency have been developed. These include 
the star-shaped copolymers [15, 16], comb-shaped copolymers [17-19] and polymers 
with grafting low molecular weight PEI [20-22].  
   Cyclodextrins (CDs) are natural cyclic oligosaccharides that have a 
hydrophobic inner cavity and a hydrophilic exterior, and this inner cavity can interact 
with various hydrophobic molecules to form supramolecular inclusion complexes 
[23]. They have low toxicities and do not induce immune responses in mammals [24]. 
Because of these highly desirable characteristics, CDs have been profusely exploited 
to improve bioavailability of poorly soluble drugs, to prevent side effects or to 
enhance membrane permeability in pharmaceutical industry. Davis and coworkers 
were the first group to introduce CD-based polymers for gene delivery [25]. Since 
then, numerous attempts have been reported to utilize CDs to deliver nucleic acid 
with various structure, such as cross-linking CDs [26-28], CD-pendent polymers [29-
31] and polyrotaxanes [20-22]. Among CDs, β-CD has been extensively used because 
of its availability and suitable cavity size for the widest range of molecules [32]. In 
addition, the CD-containing gene delivery system can be further modified by 
inclusion complex formation [24]. Recently, A series of CD-centered, star-shaped 
polymers have been developed and evaluated for in vitro gene delivery [16,33].  
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   Hyaluronic acid or hyaluronan (HA), is a natural linear polysaccharide that 
has pivotal roles in various biological functions, such as stabilizing and organizing 
the ECM, regulating cell adhesion, motility, mediating cell proliferation and 
differentiation [34]. Due to its excellent biocompatibility and biodegradability, HA 
has been extensively investigated for biomedical applications such as tissue 
engineering [35], drug delivery [36], and molecular imaging [37]. In addition, HA 
specifically binds to its cell surface receptors, CD44 and RHAMM (receptor for HA 
mediated motility) to regulate cell proliferation and movement. CD44 activation 
enhanced its downstream pathways, e.g., Rac1, leading to tumor growth, progression 
and metastasis [38]. More recently, CD44 expressed at cell surface has been 
considered to be a stem cell marker in breast cancer [39]. Therefore, we proposed that 
the specific binding of HA to its receptor CD44 could be utilized for therapeutic 
application targeting to CD44-positive breast cancer cells. 
   In the present study, we report a new CD44-targeted gene delivery system 
for the safe and efficient delivery of therapeutic pDNA, which is based on a series of 
HA-conjugated β-CD star polymers with multiple oligoethylenimine (OEI) arms. The 
polymers, termed β-CD-OEI-HA, were synthesized by reductive amination between 
cationic β-CD-OEI star polymers and low molecular weight HA. Our data 
demonstrated that the β-CD-OEI-HA polymers exhibited low cytotoxicity, high 
efficiency to condense pDNA, and high specificity for gene delivery in CD44-
positive MDA-MB-231 breast cancer cells. In addition, β-CD-OEI-HA polymers-
mediated wild type p53 gene delivery sufficiently and effectively induced cell growth 
inhibition in the CD44-positive MDA-MB-231 cells. Our study provides a potential 
gene delivery method that specifically targeting the aggressive CD44-positive breast 
cancer cells. 
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3.2 Experimental Section  
3.2.1 Materials  
Sodium hyaluronate with a molecular weight less than 10,000 Da and 
1,000,000 Da was obtained from Lifecore Co. (Chaska, MN). Sodium 
cyanoborohydride was purchased from Acros Organics (New Jersey, U.S.A.). β-
Cyclodextrin and sodium borate were supplied by Sigma (Andover, UK). OEI600 
(branched, MW 600), PEI (branched, MW 25 kDa), 1-ethyl-3-[3-dimethyl-
aminopropylcarbodiimide (EDAC), and 1,1′-carbonyldiimidazole (CDI) were 
received from Sigma-Aldrich (Munich, Germany). Tetrahydrafuran (THF) and 
dimethyl sulfoxide (DMSO) were purchased from Merck (New Jersey, U.S.A.). 
Qiagen kit and Luciferase kit were purchased from Qiagen (Hilden, Germany) and 
Promega (Madison, U.S.A.) respectively. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT), penicillin, and streptomycin were obtained from Sigma 
(Andover, UK). Mouse monoclonal anti-human-CD44H was purchased from R&D 
systems (Minneapolis, U.S.A.). 
3.2.2 Synthesis Methods 
Synthesis of β-CD-OEI star polymer 
β-CD-OEI star polymer was synthesized as reported previously [16]. Briefly, 
a solution of β-CD (1.1 g, 1.0 mmol) in DMSO (20 mL) was added dropwise to a 
solution of CDI (3.4 g, 21.0 mmol) in DMSO (30 mL) during 1 h. After stirring for 20 
h, the above solution was added into a mixture of ether/THF (400 mL/200 mL). The 
white precipitate was collected by centrifuge and washed with ether/THF (20 mL/10 
mL) twice, then dissolved into anhydrous DMSO (20 mL). The mixture was then 
added dropwise into a solution of OEI600 (12.6 g, 21.0 mmol) in DMSO (40 mL). 
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The reaction mixture was then stirred at room temperature for 24 h. The resulting 
solution was poured into a dialysis membrane (MW cutoff 2000, Spectrum 
Laboratories Inc., RanchoDominguez, CA) and dialyzed against deionized water at 
room temperature for 5 days. The dialysate was gravimetrically filtered and 
lyophilized to yield colorless solid. 
Synthesis of β-CD-OEI-HA 
For sodium hyaluronate modification by β-CD-OEI, 11 mg of HA were 
dissolved in 10 mL of distilled water and preactivated for 2 hours at 37 ºC by 
incubation with 5 mg of EDAC at pH 4 adjusted by titration with HCl 0.1 N. 
Subsequently, a suspension of β-CD-OEI (1.21 mg in 1 mL DI water) was added to 
the HA solution and the pH was adjusted at 8.6 with a 0.1 M borate buffer PH 9.4. 
The reaction proceeded for 24 h at 37 ºC. The final solution containing the HA-β-CD-
OEI conjugate was dialyzed against distilled water using a Spectra cellulose 
membrane with a molecular cutoff of 50,000. Distilled water was changed every 8 
hours. The final product was then lyophilized. The final product was then lyophilized 
[40]. Yield: 58% (w/w). 
Another method to synthesize β-CD-OEI-HA polymers was reductive 
amination, by referring to a report synthesizing HA-PEI conjugates [41]. For β-CD-
OEI-HA, HA (21.0 mg, 2.1 μmol) was stirred in 10 mL of sodium borate buffer (0.1 
M, pH 8.5) at 40 ºC for 2 h, then a solution of β-CD-OEI in water (300.0 mg, 60.0 
μmol) was added, followed by NaBH3CN (20.0 mg, 0.3 mmol) as a reducing agent. 
The mixture was stirred for additional 48 h under the same conditions. The resulting 
solution was poured into a dialysis membrane (MW cutoff 6000, Spectrum 
Laboratories Inc., RanchoDominguez, CA) and dialyzed against deionized water at 
room temperature for 5 days. The dialysate was gravimetrically filtered and 
lyophilized to dryness. Yield: 70%. 1H NMR (400 MHz, D2O): 4.99 (brs, 7 H, H-1 of 
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β-CD), 4.30 – 4.56 (m, 3 H, H-1,1′ of HA), 2.91 – 4.30 (m, 71 H, H-2-6 of β-CD, H-
2-6 of HA, H-2′-5′ of HA, -OCONHCH2- of OEI), 2.04 – 2.90 (m, 330 H, -
NHCH2CH2- of OEI), and 1.94 (s, 4.5 H, -NHCOCH3 of HA). 
3.2.3 1H NMR Spectroscopy 
1H NMR spectra were recorded on a Bruker AV-400 NMR spectrometer at 
400 MHz at room temperature. The 1H NMR measurements were carried out with an 
acquisition time of 3.2 s, a pulse repetition time of 2.0 s, a 30° pulse width, 5208 Hz 
spectral width, and 32 K data points. Chemical shifts were referenced to the solvent 
peak (δ = 4.70 ppm for D2O and δ = 2.50 ppm for DMSO-d6). 
3.2.4 Plasmid Amplification 
The plasmids pRL-CMV that contains a Renilla luciferase reporter gene was 
purchased from Promega (Madison, USA), and pEGFP-N1 encoding a red-shift 
variant of wild-type green fluorescent protein (GFP) was obtained from Clontech 
Laboratories Inc. (Mountain View, USA). The p53 expressing plasmids pCMV-p53 
(wild type) and pCMV-p53mt135 (mutant p53, dominant negative) were purchased 
from Clontech Laboratories Inc. (Mountain View, USA). All plasmids were amplified 
in E. Coli and purified by using a commercialized kit according to the supplier's 
protocol (Qiagene, Hilden, Germany). The quantity and quality of the purified pDNA 
was assessed by optical density at 260 and 280 nm and by electrophoresis in 1% 
agarose gel. The purified plasmids were resuspended in TE buffer (10 mM Tris-Cl, 
pH7.5, 1 mM EDTA) and kept in aliquots at a concentration of 0.5 mg/mL. 
3.2.5 Cells and Media 
All cell lines were purchased from the American Type Culture Collection 
(ATCC, Rockville, MD). MDA-MB-231 and MCF-7 cells were maintained in 
Dulbecco’s Modified Eagle's Medium (DMEM) supplemented with 10% heat-
Chapter 3: Hyaluronic Acid Conjugated β-Cyclodextrin-Oligoethylenimine 
Copolymers for CD44-Targeted Gene Delivery 
59 
inactivated fetal bovine serum, 100 units/mg penicillin, 100 µg/mL streptomycin at 
37 °C and 5% CO2. SKBr3 cells were cultured in McCoy5A medium with 10% FBS, 
BT549 cells were cultured in RPMI 1640 medium with 10% FBS and MCF10A cells 
were cultured in MEGM medium with BPE. 
3.2.6 Western Blot Analysis of CD44 Expression in Breast Cell Lines 
Cellular proteins from the cell cultures were extracted using RIPA buffer 
supplemented with complete, EDTA-free protease inhibitor cocktail tablets (Roche 
Diagnostics, Indianapolis, IN) and phosphatase cocktail inhibitors I and II (1:100), 
and kept on ice for 1 hour. The cell lysates were then centrifuged at 4 ºC for 30 
minutes and the supernatants were collected. Protein concentrations were determined 
using the Commassie PlusTM Protein Assay Reagent (Pierce). Proteins were 
separated by 10% SDS-PAGE and transferred onto PVDF membranes. The 
membranes were probed with monoclonal mouse anti-CD44H (1:200) and 
monoclonal mouse anti-β-actin (1:5000) overnight at 4 ºC. Goat-anti-mouse IgG 
horseradish peroxidase (HRP 1:5000) was used as secondary antibody. The 
chemiluminescent signals were visualized using SuperSignal West Pico 
Chemiluminescent Substrate (Pierce). Signals were captured with the MULTI 
GENIUS BioImaging System (Syngene) and the signal intensities were analyzed 
using the GeneTools software (Syngene). 
3.2.7 Immunofluorescence Assay of CD44 Distribution in Breast Cell 
Lines 
Cells plated on coverslips were fixed with 4% paraformaldehyde (Sigma-
Aldrich) for 20 min and permeabilized with 0.1% Triton X-100 for 10 min. The cells 
were then incubated overnight with monoclonal mouse anti-CD44H at 4 ºC, followed 
by incubation with Alexa Fluor 488-conjugate streptavidin (1:2000, Invitrogen) for 1 
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h at room temperature. Actin filaments were stained with rhodamine-phalloidin 
(1:1000, Invitrogen) for 45 min. After the final washes with PBS, the coverslips were 
mounted using an antifade mounting fluid containing DAPI and images were 
examined and captured using an Olympus Fluoview FV500 confocal laser scanning 
microscope (Olympus, Japan). Raw images were analyzed using Olympus FV10-
ASW 1.7 Viewer software (Olympus). 
3.2.8 Gel Retardation Experiment 
The polymers β-CD-OEI-HA were examined for their ability to bind pRL-
CMV by gel retardation assay. In general, polyplexes were prepared by adding 5 µL 
of polymer solution dropwise to 5 µL plasmid solution (100 µg/mL), followed by 
vortexing for 6 s. The polyplex solutions were incubated for 30 min at room 
temperature. After mixing 1.5 µL of loading buffer (10×) with polyplex solutions, 
11.5 µL of polyplex solution were analyzed on 0.8% agarose gel containing 0.5 
µg/mL ethidium bromide. Gel electrophoresis was carried out in 1×TAE buffer (40 
mM Tris-acetate, 1 mM EDTA) at 110 V for 35 min in a Sub-Cell system (Bio-Rad 
Laboratories, CA). DNA bands were visualized by MULTI GENIUS BioImaging 
System (Syngene). 
3.2.9 Cell Viability Assay 
Two cell lines (MDA-MB-231 and MCF-7) were cultured in DMEM medium 
supplemented with 10% FBS at 37 °C with 5% CO2 in a humidified incubator. One 
hundred µL of cell suspension were seeded at a density of 1×105 cells/mL into 96-
well plates (NUNC, Wiesbaden, Germany). After 24 h, culture media were replaced 
with media containing serial dilutions of polymers or polyplexes at various N/P ratios 
and the cells were incubated for another 24 h. Then, 10 µL sterile filtered MTT (5 
mg/mL) stock solution in PBS was added to each well. After 4 h post-incubation, the 
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medium including the unreacted dye was removed by aspiration and the cells were 
washed twice with PBS. The formazan crystals were dissolved in 100 µL DMSO per 
well and the absorbance measured at a wavelength of 570 nm in a microplate reader 
(Spectra Plus, TECAN).  
3.2.10 In Vitro Transfection and Luciferase Assay 
For in vitro transfection studies, cells were seeded into 24-well plate at a 
density of 5×104 per well in 0.5 mL of medium with antibiotics 24 h prior to 
transfection. Three hours before transfection, the medium in each well was replaced 
with 0.3 mL of serum-containing medium in the presence or absence of free HA (0.1 
mg/mL and 1 mg/mL). At the time of transfection, polyplexes containing 1 µg pDNA 
were added to each well and incubated for 4 h under standard culture condition. Then 
the medium was replaced with 0.5 mL of fresh medium and cells were incubated for 
another 20 h under the same conditions. At the end of transfection, cells were washed 
with preheated PBS twice, lysed with 100 µl of cell lysis buffer (Promega) for 30 min. 
The luciferase activity in cell extracts was measured using a luciferase assay kit 
(Promega) on a single-well luminometer (Berthold lumat LB9507, Germany) for 10 
sec. The relative light units (RLU) were normalized against protein concentration in 
the cell extracts, which was measured using Commassie PlusTM Protein Assay 
Reagent (Pierce). Absorption was measured on a microplate reader (Spectra Plus, 
TECAN) at 595 nm and compared to a standard curve calibrated with BSA. Results 
are expressed as relative light units per milligram of cell protein lysate (RLU/mg 
protein).  
3.2.11 Dynamic Light Scattering and Zeta-potential Measurements 
Measurements of particle size and zeta potential of the complexes were 
performed using a Zetasizer Nano ZS (Malvern Instruments, Southborough, MA, 
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USA) with a laser light wavelength of 633 nm at a 173° scattering angle. Complex 
solutions (100 µL) containing 3 µg of pDNA (pRL-CMV) were prepared at various 
N/P ratios ranging from 2 to 30. The mixture was vortexed for 20 s, incubated for 30 
min at room temperature and diluted in 1mL of the distilled water before being 
analyzed on the Zetasizer. The size measurement was performed at 25 °C in triplicate. 
The deconvolution of the measured correlation curve to an intensity size distribution 
was accomplished using a nonnegative least squares algorithm. The Z-average 
hydrodynamic diameters of the particles were given by the instrument. The Z-average 
size is the intensity weighted mean diameter derived from a Cumulants or single-
exponential fit of the intensity autocorrelation function. The zeta potential 
measurements were performed using a capillary zeta potential cell in automatic mode. 
3.2.12 In Vitro Green Fluorescence Protein Expression 
Plasmid pEGFP-N1 (Clontech Laboratories Inc.) encoding a red-shifted 
variant of wild type green fluorescence protein (GFP) was used to examine the GFP 
expression. In brief, MDA-MB231 cells were seeded into 12-well plates (NUNC, 
Wiesbaden, Germany) at a density of 1 × 105 cells/well in 1 mL of complete DMEM. 
After 16 h, 500 µL of fresh complete DMEM, containing 20 µL polyplexes with 2 µg 
of pDNA were added. After 4 h, the transfection media was removed and the cells 
were continued to incubate in complete DMEM for another 20 h. At the end of 
transfection, the cells were washed with warm phosphate-buffered saline (PBS) twice 
and collected, followed by fixing with chilled 4% paraformaldehyde solution for 1 h 
on ice. The cells were centrifuged again, and the paraformaldehyde solution was 
replaced with PBS. The cells were counted using flow cytometry (FACSCalibur, 
Becton Dickinson, NJ). A maximum limit of 1 × 104 cells per sample was 
implemented on the gated population of all experimental groups.  
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3.2.13 Cell Cycle Analysis 
The p53 Dominant-Negative Vector Set was used to monitor p53-mediated 
apoptosis. This vector set consists of two vectors, pCMV-p53 and pCMV-p53mt135. 
pCMV-p53 expresses the wild-type p53 tumor suppression protein and pCMV-
p53mt135 expresses a dominant-negative mutant, which is used as negative control. 
Transfection was performed as described previously [20]. At the end of transfection, 
cells were collected, washed with phosphate-buffered saline (PBS, pH 7.4) and fixed 
with ice-cold 70% ethanol for 60 min at 4 °C. After washing with PBS, cells were 
permeabilized with 0.2% Triton X-100 for 5 min and then stained with 1 mL 
propidium iodide/RNase staining buffer (BD Biosciences, San Diego, CA) for 60 min. 
The percentage of distribution of cells in the various phases of cell cycle (sub G1, 
G0/G1, S and G2/M) was quantified using flow cytometry (FACSCalibur, Becton 
Dickinson, NJ). 
3.2.14 Statistical Analysis 
  Statistical analysis was performed using a standard Student's t-test with a 
minimum confidence level of 0.05 to assess statistical significance of difference 
between group means. All cell experiments were performed in triplicates and the 
results are expressed as mean ± standard deviation. 
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3.3 Results and Discussion 
3.3.1 Synthesis and Characterization of β-CD-OEI-HA 
(EDC)
37 ºC, PH=4, 2 hours
(β-CD-OEI, x=14)


























































































































Figure 3.1. Synthetic scheme 1 of β-CD-OEI-HA ǀ. 
β-CD-OEI-HAǀ polymers were synthesized by the reaction between the 
carboxyl groups of HA and amine groups of β-CD-OEI (Figure 3.1). Figure 3.2 
shows the 1H NMR results of HA-β-CD-OEI (molar ratio: 1:20) in comparison with 
pure HA and β-CD-OEI. The spectra of HA have signals at 1.9 ppm and 3.8~3.2 ppm, 
which were attributed to the methyl protons in acetamide groups and the protons in 
the sugar ring of HA, respectively [42]. The spectra of HA-β-CD-OEI has both a 
methyl peak of acetamide group of HA at 1.9 ppm and an OEI peak at 2.8 ppm. This 
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Figure 3.2. 1H-NMR spectrum of  β-CD-OEI (A), HA (B) and β-CD-OEI-HAǀ (C) 
conjugate synthesized with a feeding molar ratio of HA to β-CD-OEI of 1:20 in 
D2O. 
Three β-CD-OEI-HAⅡ  cationic polymers were synthesized in aqueous 
buffer by reductive amination between β-CD-OEI star polymer and HA according to 
the scheme in Figure 3.3. The reduction by NaBH3CN caused cleavage of HA into 
shorter fragments. Different feed ratios of HA to β-CD-OEI resulted in β-CD-OEI-
HA with different HA contents. Figure 3.4 shows the 1H NMR spectra of β-CD-OEI-
HA polymers in comparison with the starting β-CD-OEI star polymer. The average 
number of OEI600 arms grafted onto each β-CD core is estimated to be ca. 6.1. As 
shown in Figure 3.4 (B-D), the 1H NMR spectra of β-CD-OEI-HA polymers have 
both peaks corresponding to methyl group from HA at δ 1.94 ppm and methylene 
group from OEI600 at δ 2.04 – 2.99 ppm. When the feed ratio of HA to β-CD-OEI 
increased, the strength of peaks corresponding to the methyl group of HA also 
increased. The results confirm the successful conjugation of HA to β-CD-OEI star 
polymer. To quantify the number of polymeric repeat unit (disaccharide of D-
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glucuronic acid and D-N-acetylglucosamine) of HA attached to β-CD-OEI, the peaks 
corresponding to the H of -NHCOCH3 from HA and the H of -NHCH2CH2 from OEI 
were integrated and the ratios were compared. This analysis showed that about 5, 3, 
and 1.5 repeat units of HA were grafted onto each β-CD-OEI star polymer, 





































































































































Figure 3.4. 1H NMR spectra of β-CD-OEI (A) and β-CD-OEI-HA Ⅱ (B) in D2O. 
3.3.2 Preparation and Characterization of β-CD-OEI-HA/pDNA 
Complexes 
The DNA condensation induced by a cationic polymer is a prerequisite for 
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successful gene delivery. The ability of β-CD-OEI-HA polymers to condense pDNA 
was evaluated by agarose gel electrophoresis, particle size and zeta potential 
measurements. Polyplexes were prepared by electrostatic interaction between 
positively charged β-CD-OEI-HA polymers and negatively charged pDNA at various 
N/P ratios or weight ratios. Figure 3.5 shows the gel retardation result of various β-
CD-OEI-HAⅠpolymers/pDNA complexes with increasing N/P ratios or weight ratios 
in comparison with branched PEI (25 kDa) and β-CD-OEI. Since HA is negatively 
charged, it can not condense DNA even at very high weight ratio (Figure 3.5C). 
Generally, with the increasing amount of β-CD-OEI conjugated to HA, the DNA 
condensation ability of β-CD-OEI-HA polymers also increase. When the feeding 
weight ratio of β-CD-OEI is 30 times of HA, the β-CD-OEI-HA polymer can totally 
inhibit the migration of pDNA at weight ratio of 0.4, which is comparable to PEI 
(25K). Whereas, when the HA modification is low (molar ratio 1:20), the β-CD-OEI-
HA can not retard pDNA even at weight ratio of 14 (Figure 3.5D). As a result, 
mixture of β-CD-OEI-HA (molar ratio 1:20) and β-CD-OEI was prepared for the 
following experiments. 0.125 mg/mL, 0.25 mg/mL and 0.5 mg/mL of β-CD-OEI-HA 
(molar ratio 1:20) were prepared with β-CD-OEI.  
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Figure 3.5. Electrophoretic mobility of plasmid DNA in the polyplexes formed by 
(A) PEI (25 K)/pRL-CMV, (B) β-CD-OEI/pRL-CMV, (C) HA/pRL-CMV, (D) 
HA-β-CD-OEI (1:20 molar ratio)/pRL-CMV, (E) HA-β-CD-OEI (1:10 weight 
ratio)/pRL-CMV, F) HA-β-CD-OEI (1:20 weight ratio)/pRL-CMV, (G) HA-β-
CD-OEI (1:30 weight ratio)/pRL-CMV and (H) HA-β-CD-OEI (1:20 molar ratio) 
+ β-CD-OEI {weight ratio 1:4}/pRL-CMV. 
 Figure 3.6 shows the gel retardation results of β-CD-OEI-HA Ⅱ
polymer/pDNA complexes with increasing N/P ratios in comparison with β-CD-OEI, 
branched PEI (25 kDa), and HA. β-CD-OEI-HA polymers complexed with pDNA 
efficiently and fully retarded the mobility of pDNA at an N/P ratio of 2.5, which is 
similar to β-CD-OEI and slightly lower than PEI (25 kDa), which can fully retard 
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Figure 3.6. Electrophoretic mobility of plasmid DNA in the polyplexes formed by 
β-CD-OEI-HA (A), β-CD-OEI (B), and PEI (25 kDa) (C) at various N/P ratios, 
and mixtures of HA/DNA at various weight ratios (D).  
Figure 3.7 shows the particle size and zeta potential of β-CD-OEI-HAⅡ 
polymer/pDNA complexes in comparison with β-CD-OEI/pDNA and PEI/pDNA at 
various N/P ratios. As shown in Figure 3.7A, the β-CD-OEI-HA polymer could 
efficiently compact pDNA into small nanoparticles. The particle size decreased with 
the increase of N/P ratio until the N/P ratio was 8 and then remained in the range of 
100 – 150 nm thereafter. At high N/P ratios, the β-CD-OEI-HA polymer, β-CD-OEI, 
and PEI (25 kDa) formed nanoparticles with pDNA with comparable particle sizes. 
The polydispersity indexes of all samples mostly range from 0.1 to 0.2, indicating a 
low to moderate levels of polydispersity. With the increase of N/P ratio, the surface 
net charge of β-CD-OEI-HA/pDNA complex increased and stabilized at or above the 
N/P ratio of 8 (Figure 3.7B). The addition of HA in β-CD-OEI-HA polymer led to 
relative low zeta potentials. The decrease of the complex surface charge is attributed 
to negatively charged HA and this may help to prevent the non-specific binding of β-
CD-OEI-HA/pDNA complexes to the serum proteins and/or cell membranes [43,44]. 
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Figure 3.7. Particle size (A) and zeta potential (B) of the complexes between β-
CD-OEI-HA polymer and pDNA in comparison with PEI/pDNA and β-CD-
OEI/pDNA complexes at various N/P ratios. 
3.3.3 Expression and Distribution of CD44 in Breast Cancer Cells 
The expression of CD44 in normal breast cell line (MCF-10A) and four 
breast cancer cell lines (MDA-MB-231, BT549, MCF-7 and SKBr3) was examined 
by immunoblotting. As shown in Figure 3.8, CD44 was highy expressed in the 
invasive mesenchymal-like MDA-MB-231 cells and basal-like BT549 cells, and 
weakly expressed in the basal-like normal breasr cells. In contrast, CD44 expression 
was not detected in the epithelial MCF-7 cells and SKBr3 with less invasive capacity. 
These results are consistent with, and further supported by previous study showing a 
correlation of CD44 with cancer cell invasion [45]. The existence of multiple bands 
of CD44 may indicate different isoforms that are attributed to alternative splicing or 
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Figure 3.8. Western blot of CD44 amount in breast cell lines (A. original protein 
band and B. signal intensity analyzed from GeneTools software). β-actin is used 
as loading control.  
In addition to CD44 expression, the distribution of CD44 in these cell models 
was also assessed by immunofluorescence staining. As indicated in Figure 3.9, CD44 
was predominantly localized at the membrane in the mesenchymal-like MDA-MB-
231 cells. In basal-like BT549 cells, CD44 was observed at the membrane and 
appeared to form particles as indicated by the green fluorescent dots (Figure 3.9B). 
Notably, CD44 expression was also found in the cytoplasm in this basal-like BT549 
cells. Although the non-tumorigenic MCF-10A cells showed a similar basal-like 
phenotype as to the MDA-MB-231 and BT549 cancer cells, CD44 was only 
expressed in the cytoplasm, not at the membrane (Figure 3.9C). The cytoplasmic 
localization of CD44 is unable to bind HA, since the molecular weight of CD44 
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detected in MCF-10A is too high (around 150 kDa, Figure 3.8) [45]. It was reported 
that only the 85 kDa CD44 can mediate the degradation of hyaluronan by invasion 
tumor cells [45]. In the epithelial MCF-7 cells and SKBr3 cells, CD44 was mainly 
detected in the nucleus (Figure 3.9D, E) The failure to detect CD44 expression by 
immunoblotting (Figure 3.8) in these cells is probably due to the lysis buffer used for 
protein extraction. Clearly, the nuclear localization of CD44 in MCF-7 and SKBr3 
cells excluded its binding capacity to HA, as demonstrated in the studies below. 
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Figure 3.9. Immunofluorescent detection of CD44 expression on breast cell lines, 
MDA-MB-231 (A), BT549 (B), MCF-10A (C), MCF-7 (D) and SKBr3 (E). (×60 
magnification, oil lens). Red: F-actin stained by rhodamine-phalloidin; Blue: 
Nuclei stained by DAPI; and Green: CD44 stained by Alexa Fluor 488-conjugate 
streptavidin.  
3.3.4 Cytotoxicity of β-CD-OEI-HA Polymer 
Cytotoxicity is an important parameter of cationic polymers as non-viral 
vectors and might be caused by electrostatic interactions with negatively charged 
glycocalyx of the cell surface [47]. Because cytotoxicity is related to gene 
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transfection efficiency, we next evaluated the toxic effect of β-CD-OEI-HA polymer 
on the CD44-positive MDA-MB-231 cells and CD44-negative MCF-7 cells using in 
vitro cell system. The IC50 values, which represent concentration of the polymers 
resulting in 50% inhibition of cell growth, were used for cytotoxic assessment. As 
demonstrated in Figure 3.10, the β-CD-OEI-HA polymer, compared to the PEI and β-
CD-OEI polymers, showed significant decreased cellular cytotoxic effects on cell 
viability in the two cell models. For example, in CD44-positive MDA-MB-231 cells, 
the IC50 values of β-CD-OEI-HA polymer was 33 µg/mL, while those of PEI (25 kDa) 
and β-CD-OEI were 16 and 24 µg/mL, respectively (Figure 3.10A). Similar results 
were also observed in the CD44-negative MCF-7 cells (Figure 3.10B). In MCF-7 
cells, the IC50 values of β-CD-OEI-HA polymer was 18 µg/mL, while those of PEI 
(25 kDa) and β-CD-OEI were 7 and 11 µg/mL, respectively (Figure 3.10A). As 
expected, HA modification reduces the cytotoxicity of β-CD-OEI. The reduced 
cytotoxicity of β-CD-OEI-HA might be ascribed to the electrostatic neutralization of 
positively charged OEI600 by the negatively charged HA. Similar trend was also 
found in β-CD-OEI-HA ǀ polymers (Table 3.1). 
Table 3.1. The estimated IC50 value of PEI (25 kDa), β-CD-OEI and β-CD-OEI-
HA/β-CD-OEI mixtures in MDA-MB-231 and MCF-7 cell lines. 
IC50 MDA-MB-231 MCF-7 
PEI (25 kDa) 18 µg/mL 18 µg/mL 
β-CD-OEI 88 µg/mL 57 µg/mL 
β-CD-OEI-HA/β-CD-OEI ( w/w = 1:2) 96 µg/mL 70 µg/mL 
β-CD-OEI-HA/β-CD-OEI ( w/w = 1:4) 68 µg/mL 57 µg/mL 
β-CD-OEI-HA/β-CD-OEI ( w/w = 1:8) 69 µg/mL 62 µg/mL 
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Figure 3.10. Cell viability assay of β-CD-OEI-HA polymer (A, B) and β-CD-
OEI-HA/pDNA complexes (C, D) in MDA-MB-231 cell (A, C) and MCF-7 cell (B, 
D) determined by MTT assay. Data represent mean ± standard deviation (n = 6). 
It should be noted that when β-CD-OEI-HA polymers were complexed with 
pDNA, the biocompatible HA on the shell of β-CD-OEI-HA/pDNA would also be 
possible to contribute to the reduction of cytotoxicity. Indeed, this is substantiated by 
the fact that, at N/P ration of 40, the cell viability for PEI/pDNA polyplexes was 
about 34.9%, while that for β-CD-OEI-HA/pDNA polyplexes was above 70% in the 
CD44-positive MDA-MB-231 cells (Figure 3.10C). The increased viability of the 
cells exposed to the β-CD-OEI-HA/pDNA polyplexes was also observed in CD44-
negative MCF-7 cells (Figure 3.10D). The MCF-7 cells exposed to the β-CD-OEI-
HA/pDNA polyplexes appeared to have higher cell survival rates within the N/P 
ratios tested, when comparing to the cells exposed to PEI/pDNA or β-CD-OEI/pDNA 
polyplexes. 
3.3.5 CD44-targeted DNA Delivery of β-CD-OEI-HA 
The effect of β-CD-OEI-HA polymers specifically target CD44 receptor for 
in vitro DNA delivery was investigated. Gene transfection efficiency of β-CD-OEI-
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HA/pDNA polyplexes in cells was assessed using luciferase activity assay in the 
presence of serum. Gene transfection mediated by β-CD-OEI-HA/pDNA polyplexes 
was carried out in CD44-positive MDA-MB-231 cells and CD44-negative MCF-7 
cells, because CD44 is expressed at the membrane in MDA-MB-231 cells, but not in 
MCF-7 cells (Figure 3.9). We found that the gene transfection efficiency was greatly 
dependent on the cell types and N/P ratio of the polyplexes. As shown in Figure 
3.11A, β-CD-OEI-HA/pDNA polyplexes, compared to the β-CD-OEI/pDNA 
polyplexes, showed significantly increased gene transfection efficiency (Ρ < 0.05) at 
the indicated N/P ratios in the CD44-positive MDA-MB-231 cells. As an example, 
the MDA-MB-231 cells treated with β-CD-OEI-HA/pDNA polyplexes expressed a 
luciferase activity of 4.4×109 RLU/mg protein, which is 8 times higher than those 
cells treated with β-CD-OEI/pDNA polyplexes (5.5×108 RLU/mg protein) at the N/P 
ratio of 30 (Ρ = 0.006, Figure 3.11A). Therefore, the β-CD-OEI-HA polymer is more 
efficient than β-CD-OEI in mediating gene delivery in the CD44-positive cancer cells. 
Clearly, HA in the β-CD-OEI-HA polymer plays a key role in targeting CD44 to 
enhance the gene delivery in the MDA-MB-231 cells. This is further supported by the 
finding that both the β-CD-OEI-HA and β-CD-OEI produced similar results of gene 
transfection at the indicated N/P ratios in the CD44-negative MCF-7 cells (Figure 
3.11B). Similar effect was also observed in other HA-containing gene delivery 
systems [41,48]. β-CD-OEI-HA ǀ/β-CD-OEI mixtures also showed targeted gene 
delivery to MDA-MB-231 cells. Since the synthesis procedure of β-CD-OEI-HAǀ 
used the carboxyl groups of HA, which is where HA bond to CD44, over 
modification of these carboxyl groups will inhibit HA-CD44 interaction. As shown in 
Figure 3.12, the transfection efficiency of β-CD-OEI-HA with feeding weight ratios 
of HA to β-CD-OEI of 1:10, 1:20 and 1:30 is significantly lower than that of β-CD-
OEI, although they have good DNA condensation ability. Possible reason is that HA 
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is over-modified by β-CD-OEI. When feeding weight ratios of HA to β-CD-OEI are 
1:10 and above, 70% or all carboxyl groups of HA are modified with β-CD-OEI. This 
is consistent with previous reports, which shows that the appropriate ratio of HA 
modification is around 24%, and if it is higher than 45%, HA mediated endocytosis 
will be inhibited [49]. 
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Figure 3.11. Transfection efficiency of the complexes between β-CD-OEI-HA 
polymer and pDNA in comparison with PEI/pDNA and β-CD-OEI/pDNA 
complexes in MDA-MB-231 (A) and MCF-7 (B) cells in the presence of serum. 
Data represent mean ± standard deviation (n = 3). * P < 0.05 denotes significant 
statistical difference. 
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Figure 3.12. In vitro gene transfection efficiency of the polyplexes formed by β-
CD-OEI-HA (weight ratio)/pDNA in MDA-MB-231 cells in comparison with β-
CD-OEI/pDNA and PEI/pDNA. Data represent mean ± standard deviation (n = 
4). 
The increased specificity and efficiency of β-CD-OEI-HA to CD44-positive 
cells were further demonstrated using GFP expression as an indicator. The indicated 
polymers were mixed with the plasmid pEGFP-N1 at the N/P ratio of 30 and the 
transfection efficiency was assessed by FACS (Figure 3.13). As shown in Figure 3.13, 
nearly 45% of CD-44 positive MDA-MB-231 cells treated with β-CD-OEI-
HA/pEGFP-N1 polyplexes showed a positive GFP expression, significantly higher 
than the cells treated with β-CD-OEI/pEGFP-N1 (28.5%) and PEI/pEGFP-N1 
(27.2%). In contrast, in the CD44-negative MCF-7 cells, the β-CD-OEI-HA/pEGFP-
N1 polyplexes were unable to increase the gene delivery efficiency (Figure 3.13B). 
All these results further substantiated that β-CD-OEI-HA/pDNA polyplexes 
specifically and efficiently target CD44 for enhanced gene delivery.  
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Figure 3.13. GFP expression in MDA-MB-231 (A) and MCF-7 (B) cells 
transfected with β-CD-OEI-HA/pDNA, β-CD-OEI/pDNA, and PEI/pDNA 
complexes at N/P ratio of 30. Data represent mean ± standard deviation (n = 3). 
* P < 0.05 denotes significant statistical difference. 
3.3.6 Interference of β-CD-OEI-HA Binding to CD44 by Free HA 
To further confirm that the enhanced gene transfection efficiency of β-CD-
OEI-HA polymer observed in CD44-positive MDA-MB-231 cells was induced by 
receptor mediated endocytosis, the HA competitive inhibition assay was conducted 
using β-CD-OEI-HA polymer and β-CD-OEI (Figure 3.14). It was found that the 
transfection efficiency of β-CD-OEI-HA polymer was significantly inhibited in CD44 
positive MDA-MB-231 cells by adding free HA (Figure 3.14). Especially, the 
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transfection efficiency of β-CD-OEI-HA polymer was significantly decreased (Ρ < 
0.05) when HA was added at 1.0 mg/mL, compared to the efficiency in the absence of 
HA (Figure 3.14A). However, the presence of HA did not clearly affect the 
transfection efficiency of β-CD-OEI and PEI (Figure 3.14A). Similarly, addition of 
HA was unable to markedly interfere with β-CD-OEI-HA mediated transfection in 
the CD44-negative MCF-7 cells (Figure 3.14B). These findings indicate that the 
presence of HA at a high concentration could actively bind to CD44 receptors, 
leading to an interruption for β-CD-OEI-HA polymers to “anchor” on the cell surface 
[50]. Our data strongly suggest that the HA-incorporated β-CD-OEI-HA vector offers 
a targeted gene delivery system with enhanced transfection efficiency in CD44-
positive cancer cells. 
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Figure 3.14. Luciferase expression of β-CD-OEI-HA/pDNA, PEI/pDNA, and β-
CD-OEI/pDNA complexes at N/P ratio of 30 after preincubation with HA (10 
kDa) for 1 hour in MDA-MB-231 (A) and MCF-7 cells (B). Data represent mean 
± standard deviation (n = 3). * (P < 0.05) denotes significant statistical difference.  
3.3.7 Delivery of Wild Type p53 Gene to CD44-positive Cancer Cells by β-
CD-OEI-HA 
The protein encoded by p53 gene is a common tumor suppressor which plays 
a critical role in diverse cellular pathways, such as DNA repair, regulation of cell 
cycle, and cell apoptosis [51]. It has been reported that p53 gene is mutated in nearly 
50% of human cancers. Mutant p53 loses its ability to control cell cycle and cell 
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apoptosis, resulting in tumor growth. Hence, functional restoration of wild type p53 
in cancer cells can suppress cell proliferation and stimulate apoptosis. This was 
evidenced by the fact that adenovirus-mediated p53 delivery showed tumor regression 
in clinical trials, although this method has been limited in intra-tumor injection [52].  
   This study has aimed to develop an efficient gene delivery system that 
specifically targets CD44 for CD44-positive cancer cell therapy; and the β-CD-OEI-
HA polymer has been proved to efficiently target CD44 for gene delivery. The p53 
gene is mutated in the CD44-positive MDA-MB-231 cells [53], leading to an 
oncogenic function. Therefore, we examined whether delivering wild type p53 via the 
CD44-targeted β-CD-OEI-HA polymers could functionally antagonize mutant p53 to 
inhibit cell growth of the CD44-positive MDA-MB-231 cells. For this purpose, two 
plasmids pCMV-p53 and pCMV-p53mt135 were used. pCMV-p53 expresses the 
wild-type p53 tumor suppression protein and pCMV-p53mt135 expresses a mutant 
p53 protein that does not have tumor suppression effect, which is used as negative 
control. The cell cycle diagrams and cell cycle analysis results are shown in Figure 
3.15 and Table 3.1. In fact, treatment of the CD44-positive MDA-MB-231 cells with 
β-CD-OEI-HA/pCMV-p53 polyplexes resulted in a significantly large cell population 
at sub G1 (38.3%, Table 3.1, Figure 3.15A), compared to the very small cell 
populations at sub G1 for those treated with β-CD-OEI/pCMV-p53 (6.4%, Table 3.1) 
and β-CD-OEI-HA/pCMV-p53mt135 (7.0%, Table 3.1, Figure 3.15B). The results 
indicate a remarkable enhancement of cell apoptosis caused by efficient delivery of 
wild-type p53 gene mediated by the β-CD-OEI-HA polymer. This is also in 
agreement with the previous results obtained from Figures 3.11 and 3.13, whereas β-
CD-OEI-HA showed higher efficiency over β-CD-OEI in CD44-targeted gene 
delivery. Clearly, these data further suggest the newly developed β-CD-OEI-HA 
polymer may be a promising non-viral vector for targeted cancer gene therapy. 
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Figure 3.15. Representative cell cycle diagrams of MDA-MB-231 cells 
transfected with β-CD-OEI-HA/pCMV-p53 (A), β-CD-OEI-HA/pCMV-
p53mt135 (B), β-CD-OEI/pCMV-p53 (C), and β-CD-OEI/pCMV-p53mt135 (D) 
polyplexes. R1 to R4 indicate sub G1 phase, G0/G1 phase, S phase, and G2/M 
phase, respectively. 
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Table 3.2. Cell Cycle Analysis Results of MDA-MB-231 Cells Transfected with 
β-CD-OEI-HA/pCMV-p53 and β-CD-OEI/pCMV-p53 Polyplexes in Comparison 
with β-CD-OEI-HA/pCMV-p53mt135 and β-CD-OEI/pCMV-p53mt135 
Polyplexes. 
Polymers  
pCMV-p53     pCMV-p53mt135  
SubG1 G0/G1  S  G2/M     SubG1  G0/G1  S  G2/M  
β-CD-OEI 6.4±0.4  73.2±2.2  10.3±2.1  9.8±0.4   3.6±0.1  68.5±1.1  11.7±0.3  15.8±0.7  
β-CD-OEI-HA 38.3±2.7  51.3±3.4  6.5±0.1  3.7±0.6     7.0±0.3  66.4±0.9  12.6±0.3  14.0±0.2  
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3.4 Conclusions 
We successfully developed a new CD44-targeted gene delivery vector by 
reductive amination between β-CD-OEI star polymer and HA. From 1H NMR spectra, 
it was estimated that 1.5 repeat units of HA disaccharide were grafted onto β-CD-OEI 
to form β-CD-OEI-HA. The β-CD-OEI-HA polymer could fully inhibit the migration 
of pDNA on agarose gel through formation of complexes with pDNA. The complexes 
between β-CD-OEI-HA polymer and pDNA formed nanoparticles with sizes ranging 
from 100 to 200 nm at N/P ratios of 8 or higher. The conjugation of HA onto the β-
CD-OEI polymer reduced the zeta potential and cytotoxicity of β-CD-OEI-
HA/pDNA polyplexes, probably due to the negatively charged HA that partially 
neutralized the OEI arms of the cationic polymers. Most importantly, the β-CD-OEI-
HA polymer demonstrated significant increased gene transfection efficiency in 
CD44-positive MDA-MB-231 cancer cells comparing with the PEI (25 kDa) and β-
CD-OEI star polymers. Finally, the successful delivery of wild type p53 gene by β-
CD-OEI-HA polymer in CD44-positive MDA-MB-231 cancer cells resulted in an 
increased cell cycle arrest at sub-G1 phase, indicating that the β-CD-OEI-HA 
polymer may be promising for efficient cancer gene therapy for the CD44-positive 
subtypes. 
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CHAPTER 4 CYCLODEXTRIN-BASED 
POLYPSEUDOROTAXANE HYDROGELS FOR 
SUPRAMOLECULAR ANCHORING OF DNA 
POLYPLEXES AND SUSTAINED GENE DELIVERY  
4.1 Introduction  
Great progress has been made in gene therapy with the use of cationic 
polymers as non-viral vectors in the past decades [1,2]. The use of these cationic 
polymers has effectively mitigate concerns over immunogenicity, mutagenicity and 
cogenicity associated with viral-based vectors [3]. Cationic polymers or polycations 
are able to condense large gene into smaller polyplexes and mask their negative 
charges, providing protection from extracellular nuclease digestion and efficient 
delivery of plasmid into cells [4]. Moreover, non-viral gene therapy involving 
polymers are generally more economical and stable. They can be produced in large 
scale with well defined structure and chemical properties [5]. So far, a variety of 
cationic polymers have been proposed and investigated for gene delivery, including 
polyethylenimine (PEI) [6], poly(L-lysine) [7], poly(amidoamine) (PAMAM) [8-12] 
and its dendrimer [13] poly(L-glutamic acid) [14] polyphosphoester [15], chitosan 
[16], poly(2-dimethylamino) ethyl methacrylate (PDMAEMA) [17,18], and others 
[5,19-25]. However, most of these systems are toxic and their resultant gene 
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expression is transient due to the eventual loss of unintegrated plasmid DNA (pDNA) 
from transfected cell nuclei. Gene transfection efficiency, as a result, diminishes 
rapidly over time. These necessitate repeated administration of DNA polyplexes to 
maintain the therapeutic level for an effective therapy [26,27]. 
Sustained gene delivery systems, acting as localized depot of genes, can 
maintain the long term local availability of DNA vectors to surrounding tissues and 
achieve a sustained systemic protein production, circumventing the need for repeated 
administration [26]. It was reported that sustained gene expression is more effective 
than repetitive single dose administrations, and the extended release of genes provides 
high transient expression for treatment of certain localized diseases, such as 
angiogenesis [28] and reproducible tissue regeneration [29]. Besides, the prolonged 
presence of the delivered genes in the cell microenvironment within the desired range 
can improve the effectiveness of drug by increasing patient compliance, reducing 
toxicity and requiring fewer administrations [26,30]. Matrices in various forms such 
as nano-spheres [31], micro-spheres [32], scaffolds[33] and hydrogels [30,34-36] 
fabricated from both natural and synthetic polymers have been studied as sustained 
delivery devices. Among these matrices, hydrogels have distinct advantages in 
rendering suitable protection over DNA and good gene loading efficiency. They 
further allow easy control on the release behavior of encapsulated gene through 
modulation of hydrogel network compositions [35]. However, hydrogel systems with 
encapsulated naked DNA often suffer from low gene transfection efficiency and rapid 
loss of naked DNA. Recent efforts are hence directed towards the design of hydrogel 
systems that encapsulate DNA polyplexes instead of naked DNA [37-40]. To this end, 
pDNA is designed to bind electrostatically to cationic functional groups within the 
hydrogel matrix and being released upon hydrogel dissolution or degradation. This 
complexation protects the pDNA from degradation by DNase attack and as hydrogel 
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degrades, the encapsulated pDNA is released and provides a sustained local DNA 
concentration for sustained gene transfection into cells [30,37]. 
Supramolecular hydrogels based on polypseudorotaxane formation between 
cyclodextrins (CDs), a class of cyclic oligosaccharide, and polymer have showed 
great potential as biomaterials due to their thixotropic nature and excellent 
biocompatibility [5,41]. Since its first report in 1994 [42], supramolecular hydrogels 
self-assembled from the host-guest inclusion complexes between CDs and 
biodegradable block copolymers have been explored for various biomedical 
applications and recent developmental efforts have greatly improved the rheological 
and application properties of this hydrogel system [5,43]. Recently, we have reported 
a group of novel supramolecular hydrogels developed from α-CD and biodegradable 
block copolymers [44-48]. These studies revealed that the incorporation of 
hydrophobic poly[(R)-3-hydroxybutyrate] (PHB) or poly(caprolactone) (PCL) 
segments in the guest polymers strengthened the resultant hydrogel and afforded 
much longer controlled release of drugs when compared with α-CD/poly(ethylene 
glycol) (PEG) supramolecular hydrogels [5,44,48,49].   
In the present study, we designed a new route to encapsulate pDNA complex 
by a supramolecular hydrogel matrix for sustained gene delivery. The design 
consideration and strategy is schematically illustrated in Figure 4.1. Firstly, well-
defined biodegradable triblock copolymers, methoxy-poly(ethylene glycol)-b-poly(ε-
caprolactone)-b-poly[2-(dimethylamino)ethyl methacrylate] (MPEG-PCL-
PDMAEMA), were used to condense pDNA into polyplexes. Previous study has 
demonstrated the excellent pDNA binding ability of MPEG-PCL-PDMAEMA block 
copolymer and its promising applications as drug and gene carrier [50]. However, the 
use of this MPEG-PCL-PDMAEMA block copolymer in sustained gene delivery, 
especially within a supramolecular hydrogel matrix, has not been explored. Through 
carefully control of each segment length within MPEG-PCL-PDMAEMA chains, 
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MPEG-stabilized biodegradable DNA nanoparticles with size suitable for cell 
internalization could be formed. In addition, the multiple MPEG chains that are 
located at the corona of these DNA nanoparticles can be used as crosslinking moieties 
to anchor the DNA nanoparticles within α-CD/PEG supramolecular hydrogel system. 
Such supramolecular crosslinking phenomenon also leads to formation of stronger 
hydrogels. Upon hydrogel dissolution, the anchored DNA polyplexes will prevent 
uncontrolled DNA release. In view of the ease of preparation that is free of organic 
solvent, the hydrogel’s thixotropic nature and controlled release property, this simple 
DNA entrapment strategy has immense potential in injectable sustained gene delivery 
system. This study would provide a profound understanding of the interaction 
between nanoparticles and supramolecular hydrogel substrates and open up a new 
approach for designing novel sustained gene delivery system. 
4.2 Experimental Section  
4.2.1 Materials  
Methoxy poly(ethylene glycol) (MPEG, Mn = 5 kDa) was purchased from 
Aldrich. Purification of MPEG was performed by dissolving the as received polymer 
in dichloromethane followed by precipitation in diethyl ether and vacuum dried 
before use. ε-Caprolactone (ε-CL, 97%) was purchased from Aldrich. It was dried 
over calcium hydride (CaH2) for 48 h at room temperature and distilled under reduced 
pressure before use. Stannous octoate [Sn(Oct)2] (95%), 2-bromoisobutyryl bromide 
(98%), 1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA, 99%), copper(I) 
bromide (CuBr, 99%), triethylamine (>99%), 1,6-diphenyl-1,3,5-hexatriene (DPH), 
anhydrous toluene (99.8%), anhydrous tetrahydrofuran (99.9%) and anhydrous N,N-
dimethylformamide (99.8%) were purchased from Sigma-Aldrich. 2-
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(dimethylamino)ethyl methacrylate (DMAEMA) stabilized with hydroquinone 
monomethyl ether was obtained from Merck and used as received.  
4.2.2 Synthesis of MPEG-PCL-PDMAEMA Triblock Copolymers 
Triblock copolymer MPEG-PCL-PDMAEMA was synthesized by a 
combination of ring opening polymerization (ROP) and atom transfer radical 
polymerization (ATRP), as illustrated in Figure 4.2. This technique was based on the 
previously reported method with revision [51,52]. Typically, the starting materials 
MPEG and ε-CL were located into a dry and nitrogen purged polymerization tube at 
molar ratio of 1:10. The polymerization was performed at 120 °C in anhydrous 
toluene for 24 h in the presence of Sn(Oct)2 as catalyst. Purified MPEG-PCL-OH was 
obtained by precipitation of the reaction mixture in excess cold diethyl ether twice 
followed by vacuum dry at 65 °C overnight (yield, 87.8%). Subsequently, MPEG-
PCL-OH diblock copolymer was modified into ATRP macroinitiator by esterification 
reaction with 2-bromoisobutyryl bromide in anhydrous THF. A 20 times excess of the 
stoichiometric amount of -OH groups was added and triethylamine was used to trap 
the hydrobromic acid generated during the reaction. For purification, the insoluble 
ammonium salt was firstly removed by centrifuge followed by precipitating the 
concentrated reaction solution in excess cold diethyl ether twice. MPEG-PCL-Br 
macroinitiator was harvested after drying under vacuum at 50 °C overnight (yield, 
93.0%). At the final stage, MPEG-PCL-PDMAEMA triblock copolymers were 
prepared by controlled ATRP. The molar feed ratio at [MPEG-PCL-Br] : 
[DMAEMA] : [CuBr] : [HMTETA] = 1 : 1000 : 1 : 2 was applied for all polymer 
synthesis. MPEG-PCL-Br macroinitiator was firstly introduced into a nitrogen filled 
round bottom flask (RBF) followed by addition of DMF and DMAEMA monomer 
through syringe injection, respectively. Afterwards, the RBF was refilled with 
nitrogen by using vacuum-nitrogen-circling system three times. HMTETA and CuBr 
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were added quickly under nitrogen atmosphere. Polymerization was allowed to 
proceed under continuous stirring at 55-65 °C for 24-72 h. The reaction was stopped 
by diluting with THF and exposing the system for 1 h. Catalyst complex was 
removed by passing a short neutral aluminium oxide column. Products were 
precipitated the concentrated THF solution in excess ether and collected by centrifuge. 
4.2.3 Characterization Methods 
4.2.3.1 Molecular Characterization 
1H and 13C NMR spectra were recorded on a Bruker AV-400 NMR 
spectrometer at room temperature. Chemical shift at 7.26 ppm and 77.2 ppm were 
referred to the solvent peaks CHCl3 in 1H and 13C NMR spectra, respectively. 
Copolymer compositions were evaluated by integrating the proton chemical shifts of -
CH2- in PCL unit at 4.1 ppm, the area of -OCH2- in PEG unit at 3.6 ppm and peak 
area of -CH2N= in PDMAEMA at 2.6 ppm. Nitrogen content was recorded on an 
EA1112 Automatic Elemental Analyzer. Samples in the weight range of 1.80-2.00 
mg were loaded into an aluminum sample cup and then were placed onto the 
sampling cartridge. The measurement was performed at 950 °C with a constant 
carrier gas flow rate at 140 mL/min. Sulfanilamide was used as a standard and was 
analyzed before use. Gel permeation chromatography (GPC) analysis was carried out 
with a Shimadzu SCL-10A and LC-8A system equipped with a Shimadzu RID-10A 
refractive index detector. THF was used as the eluent at a flow rate of 0.30 mL/min at 
40 oC. Monodispersed PEG standards were used to obtain a calibration curve. 
4.2.3.2 Critical Micellization Concentration (CMC) Determination by UV 
Spectroscopy 
CMC values were determined by using the dye solubilization method [53]. 
The hydrophobic dye 1,6-diphenyl-1,3,5-hexatriene (DPH) was dissolved in methanol 
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with a concentration of 0.6 mM. Ten microliters of this solution was mixed with 1.0 
mL of copolymer aqueous solution with concentrations ranging from 1 × 10-4 to 1 
mg/mL and equilibrated overnight at 4 °C. A UV–vis spectrophotometer was used to 
obtain the UV-vis spectra in the range of 330-430 nm at 25 °C. The CMC value was 
determined by the plot of the difference in absorbance at 378 nm and at 400 nm 
(A378-A400) versus logarithmic concentration. 
4.2.3.3 Plasmid Amplification and Cell line 
Plasmid pRL-CMV (Promega, USA), which encodes Renilla luciferase that 
was originally cloned from the marine organism Renilla reniformis, was used as 
reporter gene in this study. The pDNA was amplified using reported protocol [27]. 
COS7 cell lines were purchased from ATCC (Rockville, MD) and maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% heat-
inactivated fetal bovine serum, 100 units/mg penicillin, 100 mg/mL streptomycine at 
37 °C and 5% CO2. DMEM medium was purchased from Gibco BRL (Gaithersburg, 
MD). Reduced serum medium (Opti-MEM) was purchase from Invitrogen (Carlsbad, 
CA). 
4.2.3.4 Formation and Characterization of Polymer/pDNA Polyplexes 
Copolymer to DNA ratios are expressed as molar ratios of nitrogen (N) in 
DMAEMA of the triblock copolymer to phosphate (P) in pDNA, and written as N/P. 
The stock solution of pDNA (0.7 μg/μL) and copolymer (0.50 mg/mL) were mixed in 
PBS buffer solution (10 mM, pH 7.4) to form polyplexes with various N/P ratios. 
After votexing for 10 s, the polyplexes were incubated for 30 min at room 
temperature before further operation. The mean particle size and the surface charge of 
copolymer particles before and after pDNA complexation were measured on a 
Zetasizer Nano ZS (Malvern Instruments Ltd., MA, USA), with a laser light 
wavelength of 633 nm at 173°. 17 μL of polyplex solution that contained 3 μg of 
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DNA was diluted to 1 mL with filtered distilled water at the time of measurements. 
Zeta potential measurements were performed using a capillary zeta potential cell in 
automatic mode. The polymer nanoparticle and polyplexes morphologies were 
observed on a high-resolution transmission electron microscope (Philips CM300 
FEGTEM) (TEM) operated at an accelerating voltage of 300 kV. 
4.2.3.5 Formation and Characterization of Supramolecular Hydrogel 
Freshly prepared polyplexes at specific N/P ratios were used as stock solution 
in supramolecular hydrogel preparation. After incubation for 30 min at room 
temperature, PEG (Mn = 10 kDa) was added into the polyplex solution to give a final 
PEG concentration of 1% (w/v). The mixture was votexed for 10 s and incubated for 
10 min at room temperature. At this step, colloidally stabilized nanoplexes were 
formed. To obtain the supramolecular hydrogel, α-CD (8%, w/v) was added and 
mixed homogenously. The solution was then kept at 4 °C overnight to allow the 
formation of hydrogel for further study. The formulations of the supramoleuclar 
hydrogels investigated in this paper were listed in Table 4.2. The gelation time (Gt) 
was estimated using a vial-tilting method [54]. Rheological assessments on the 
hydrogels were performed on a Thermo Haake RS600 rheometer based on our 
previously reported method [54]. Oscillatory frequency sweeps were done from 100 
to 0.1 rad/s at a constant shear stress of 5.0 Pa. The applied stress is within the linear 
viscoelastic region of the hydrogels. Oscillatory stress sweeps were performed by 
applying increasing shear stress logarithmically from 5.0 Pa at a fix angular 
frequency of 1 rad/s until the hydrogels were destroyed, as evidenced by a G′/G″ 
crossover, and 100% deformation was reached.  The same degree of deformation was 
maintained for 30 s. Then the applied shear stress was reduced to 5 Pa to monitor 
structural recovery. The time interval for the destroyed hydrogels to recover to the 
point of G′ = G″ was defined as the recovery time, tR. Supramolecular gelation as 
induced by α-CD polypseudorotaxane formation was investigated by Bruker GADDS 
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X-ray diffractometer with an area detector, operating under Cu-Kα (1.5418 Å) 
radiation (40kV, 40mA) at room temperature. The samples were scanned from 5 to 
40° (2θ). 
4.2.3.6 Dissolution study 
Supramolecular hydrogels containing polymer/pDNA nanoparticles (total 
volume 400 μL) were formulated in 1.5 mL sample vials. 400 μL of PBS buffer 
solution (10 mM, pH 7.4) was subsequently added on top of a hydrogels as release 
media. The sample vials were transferred into a portable shaking incubator and 
shaked at a rate of 50 rpm at 37 °C. At different time intervals, the release media were 
collected from each sample and replaced with 400 μL of fresh pre-warmed PBS 
buffer. After incubating the release media with 1% (w/v) heparin for 30 min, the 
concentration of the released DNA was measured using fluorescence picogreen assay 
on a FLUOstar OPTIMA microplate reader. 
4.2.3.7 Gel Retardation Assay 
The binding ability of MPEG-PCL-PDMAEMA triblock copolymers to 
pDNA was examined by gel electrophoresis. After adding 5 × loading buffer with 
polyplex solutions, samples were loaded on a 0.9% agarose gel stained with 0.5 
mg/mL ethidium bromide. The gels were run in 1 × TAE buffer (40 mM Tris-acetate, 
1 mM EDTA) at 100 V for 30 min in a Sub-Cell system (Bio-Rad Laboratories, CA). 
DNA bands were visualized with a UV lamp on GelDoc system (Synoptics Ltd., UK). 
4.2.3.8 Transfection Efficieny 
COS7 cells were grown in 24-well plates to 70 - 80% confluence. They were 
then transfected with freshly prepared copolymer/pDNA polyplex or the polyplexes 
released from the supramolecular hydrogels collected at various time points. 
Polyplexes containing 0.75 μg pDNA in 300 μL growth media were added to each 
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well and were incubated with the cells for 4 h. After that, the copolymer solution was 
replaced with 500 μL of fresh DMEM and cells were further incubated for 20 h under 
standard culture condition. At the end of transfection, cells were washed with 
preheated PBS twice, lysed with 100 ml of cell lysis buffer (Promega, USA) for 30 
min. The luciferase activity in cell extracts was measured using a luciferase assay kit 
(Promega, USA) on a single-well luminometer (Berthold lumat LB9507, Germany) 
for 10 s. The relative light units (RLU) were normalized against protein concentration 
in the cell extracts, which was measured using Coomassie Plus Protein Assay 
Reagent (Pierce, Rpckford, IL, USA). Absorption was measured on a microplate 
reader (Spectra Plus, TECAN) at 595 nm and compared to a standard curve calibrated 
with BSA samples of known concentrations. Results are expressed as relative light 
units per milligram of cell protein lysate (RLU/mg protein) [55]. 
4.2.3.9 Cell Viability Assay 
Cells were seeded in a 96-well microtiter plate (Nunc, Wiesbaden, Germany) 
at densities of 1 × 104 cells/well and cultured in complete DMEM media 
supplemented with 10% FBS at 37 °C, 5% CO2. After 24 h, culture media were 
replaced with serum-supplemented culture media containing known concentrations of 
the copolymers or the desired amount of the copolymer/pDNA polyplexes that were 
released from the supramolecular hydrogels. The cells were incubated for a further 24 
h. Then, 10 μL of sterile-filtered MTT stock solution in PBS (5 mg/mL) was added to 
each well, reaching a final MTT concentration of 0.5 mg/mL. After 5 h, unreacted 
dye was removed by aspiration. The formazan crystals were dissolved in DMSO (100 
μL/well), and the absorbance was measured using a microplate reader (Spectra Plus, 
TECAN) at a wavelength of 570 nm. The relative cell viability (%) with respect to 
control, i.e. cells cultured in media without polymers, was calculated with the formula 
[A]test/[A]control × 100%, where [A]test is the absorbance of the wells with 
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polymers and [A]control is the absorbance of the control wells. All experiments were 
conducted in triplicates and average values are reported. 
4.3 Results and Discussion 
4.3.1 Synthesis and Characterizations of MPEG-PCL-PDMAEMA 
Triblock Copolymers 
MPEG-PCL-PDMAEMA triblock copolymers were synthesized via a three-
step technique, as shown in Figure 4.2. MPEG-PCL-PDMAEMA was denoted as 
ECD, E for MPEG, C for PCL, D for PDMAEMA, and the unit number of each block 
calculated from NMR spectra was written as subscripts, following behind each 
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Figure 4.1. Design consideration of ECD/pDNA anchored α-CD/PEG 
supramolecular hydrogel.  Amphiphilic ECD forms micelles under aqueous 
environment with PCL core and MPEG/PDMAEMA corona. PDMAEMA at the 
corona is responsible for pDNA binding while MPEG serves both as stabilizing 
moiety for the resultant ECD/pDNA polyplex and hydrogel anchoring segment. 




Figure 4.2. Synthesis route of MPEG-PCL-PDMAEMA triblock copolymers. 
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During the reaction sequences, the intermediate and a series of final products 
were monitored by NMR spectroscopy. Figure 4.3 (A → C) shows the 1H NMR 
spectra of products and precursors of each step in CDCl3. In Figure 4.3A, proton 
signals belong to MPEG-PCL-OH diblock copolymer are confirmed. The signals 
corresponding to methylene protons in repeated units of PEG segments are observed 
at 3.6 ppm, the signals at 4.1 ppm are associated with methylene protons alpha to the 
ester group of PCL segments. PCL molecular weight calculated from NMR 
integration was found to be 5.03 kDa, giving an E114C44-OH diblock copolymer in 
composition after ROP. In the subsequent esterification reaction, the extent of 
substitution of hydroxyl groups can be obtained by calculating the ratio of the signal 
at 4.1 ppm (-CO-CH2-, PCL) and a signal at 1.92 ppm from the methyl protons of the 
2-bromoisobutyryl fragment. Substitution of hydroxyl group into MPEG-PCL-Br was 
estimated to be 83% based on Figure 4.3B. Triblock copolymers ECD with various 
DMAEMA unit numbers were prepared by carefully controlling the polymerization 
temperature (55 – 65 °C) and time (24 - 72 h). Table 4.1 shows the copolymers with 
different DMAEMA unit number, which represents the short, intermediate and long 
PDMAEMA segments for further structure-property study. The relative molecular 
weight and polydispersity were evaluated by GPC. The results are in good agreement 
with the molecular weight calculated from NMR spectra, as summarized in Table 4.1. 
Chemical structure of ECD triblock copolymer is shown in Figure 4.3C. As expected, 
all the peaks belong to the three components are found and split well. Comparing 
with the precursors, the new born peaks at 2.6 ppm and 0.85-1.15 ppm are 
corresponding to the protons of -CH2N= and -CH3 groups adjunct to PDMAEMA 
backbone.  
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Figure 4.3. 1H NMR spectra of (A) MPEG-PCL-OH; (B) MPEG-PCL-Br; (C) 
MPEG-PCL-PDMAEMA (E114C44D99) triblock copolymer. 
13C NMR was further applied to investigate the triblock copolymer 
architecture. As shown in Figure 4.4, signals corresponding to the methylene carbon 
alpha to the ester group of PCL segment are observed at 64.5 ppm, the signals at 71.2 
ppm are assigned to the methylene carbon of MPEG. More importantly, the signals at 
46.2 ppm associated with methyl carbon adjacent to the tertiary amino moiety in 
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PDMAEMA segment were observed. Another evidence can be witnessed from the 
methyl carbon peak associated with 2-bromoisobutyryl fragment, originally at 31.1 
ppm, it was shifted to 17.1 ppm [56]. This indicates that the bromide end of 
macroinitiator has reacted with DMAEMA monomer. Nitrogen contents of ECD 
copolymer with various PDMAEMA block lengths were obtained from elemental 
analysis. These data were used in the stoichiochemistry of encoding pDNA at specific 
N/P ratios, as well as the polyplexes preparation in supramolecular hydrogel 
fabrication. 
 
Figure 4.4. 13C NMR of E114C44D99 triblock copolymer in CDCl3. 
The three ECD copolymers were soluble in water. The CMC determination 
was carried out for these copolymers using the dye solubilization method at 25°C. 
This experiment was carried out by varying the aqueous polymer concentration in the 
range of 1 ×10-4 to 1 mg/mL, while keeping the concentration of DPH constant. DPH 
shows a higher absorption coefficient in a hydrophobic environment than in water. 
Thus, with increasing polymer concentration, the absorbances at 344, 358, and 378 
nm increased (Figure 4.5A). The point where the absorbance suddenly increases 
corresponds to the concentration at which micelles are formed. When the micelle is 
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formed, DPH partitions preferentially into the hydrophobic core formed in the 
aqueous solution [57]. The CMC was determined by extrapolating the absorbance at 
378 nm minus the absorbance at 400 nm (A378-A400) versus logarithmic 
concentration (Figure 4.5B). The CMC values are tabulated in Table 4.1. As shown 
earlier, at given both MPEG and PCL chain length of ~5 kDa, MPEG-PCL-OH was 
not homogeneously dispersed in water to form micelle solution. This may be due to 
the high hydrophobicity of PCL block. Previous CMC measurement of this polymer 
micelle solution prepared through an organic solvent/water exchange process was 
found to be 0.5 × 10-4 g/mL [58]. However, by integrating PDMAEMA block into 
MPEG-PCL backbone, the hydrophilicity increased. At certain content, this 
integration would make ECD triblock copolymer water-soluble in water, rendering 
the micelle preparation process without contacting organic solvent, which is 
important in the down-stream cell culture and gene delivery experiments. CMC 
values increased from 1.3 × 10-4 to 2.9 × 10-4 g/mL with increasing the hydrophilic 
PDMAEMA block length from short to long in our cases. The trend of on CMC 
values reflected the effect of PDMAEMA chain length. PDMAEMA is hydrophilic in 
water and the more amount increases hydrophilic/hydrophobic balance of the 
copolymer, leading to a higher concentration for micelle formation [59]. This trend 
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Table 4.1. Molecular characteristics of MPEG-PCL-PDMAEMA triblock 
copolymers and their precursor 
 
Polymer a Mn (kDa) b Mn (kDa) c PDI c N% d 
CMC e 
(×104 g/mL) 
E114C44-OH 10.03 11.76 1.12 - 0.5f 
E114C44D99 25.10 24.37 1.25 5.5 1.3 
E114C44D213 42.65 40.16 1.28 7.0 2.4  
E114C44D400 63.93 62.81 1.31 8.0 2.9 
a) MPEG-PCL-PDMAEMA triblock copolymers are denoted as ECD, where E represents 
MPEG, C represents PCL and D represents PDMAEMA, repectively. The number of 
repeating unit in each block is shown as subscripts following each block. b) Results 
calculated from NMR spectra; c) Results determined from gel permeation 
chromatography (GPC); PDI: Polydispersity index measured from GPC; d) Nitrogen 
weight content as evaluated from elemental analyses; e) Critical micellization 
concentration (CMC) determined using dye solubilization method. f) Reported CMC as 
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Figure 4.5. (A) UV-vis spectra changes of DPH with increasing E114C44D400 
triblock copolymer concentration in water at 25 °C. DPH concentration was 
fixed at 6 μM, and the polymer concentration varied between 1 × 10-4 to 1 
mg/mL. The increase in the absorbance band at 378 nm indicates the formation 
of a hydrophobic environment in water. (B) CMC determination by 
extrapolation of the difference in absorbance at 378 and 400 nm.   
4.3.2 Formation of ECD Triblock Copolymers /pDNA Complexes 
To function as polymeric gene vectors, a particular polymer must be able to 
condense DNA into polyplexes suitable for cellular uptake. The binding ability of 
ECD triblock copolymers to pDNA was examined using gel electrophoresis, with 
commercial PEI (Mn = 25 kDa) as control. Electrophoresis results of 
E114C44D213/pDNA at several N/P ratios are shown in Figure 4.6B. E114C44D213 was 
found to complex pDNA efficiently at N/P ratio of 1.0, in comparison to N/P ratio of 
2.0 for PEI. All these results confirm that ECD triblock copolymers have strong 
pDNA binding ability. 
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Figure 4.6. Agarose gel electrophoresis retardation assays for (A) PEI/pDNA 
and (B) Freshly prepared E114C44D213/pDNA polyplexes in different N/P ratios. 
(C) Mobility test of released polyplexes. Lane 1 contains pDNA released from 
Gel-4 on Day 1. D1, D3 and D5 in lanes 2, 4, 6 contain polyplexes released from 
Gel-1 on Day 1, 3, 5, respectively, and D1+, D3+ and D5+ in lanes 3, 5, 7 contain 
DNA recovered from those polyplexes after incubating them with Heparin.  
4.3.3 In vitro Gene Transfection Efficiency of ECD Triblock Copolymers 
/pDNA Complexes 
Figure 4.7A shows the gene transfection results of ECD triblock copolymers 
at different N/P ratios in 10% serum culture on COS7 cells. PEI (25 kDa, branched) 
at an optimal N/P ratio of 10 and naked pDNA (ND) were used as control. ECD 
copolymers have been shown to demonstrate good transfection efficiency in a 
previous study that used flow cytometry to assess the transfection of cyanine-5 
labeled pDNA [60]. In the present study, the transfection efficiency of ECD 
copolymers was assessed using luciferase as marker gene. Luciferase expression was 
quantified by means of luciferase activity assay. As presented in Figure 4.7A, the 
efficiency mediated by the complexes showed the highest value in E114C44D400 
copolymer with long PDMAEMA chain at low N/P ratio range of 7 to 10. It is worth 
noting that the level of gene expression mediated by E114C44D400 is higher than that 
mediated by PEI at this stage. This alludes to the effectiveness of long PDMAEMA 
blocks in pDNA binding that resulted in more stable polyplexes, which in turn lead to 
much higher transfection efficiency [61]. For ECD triblock copolymers with short 
and intermediate PDMAEMA chain length, their transfection efficiencies first 
increase with larger N/P ratios from 7 to 20 but decrease slightly when N/P ratios 
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were further increased to 30. The optimal transfection capabilities of these two 
copolymers are comparable to that of PEI. Our preliminary study suggested that the 
optimal transfection N/P ratios for E114C44D400, E114C44D213 and E114C44D99 were 7, 20, 
and 20, respectively. At optimal N/P ratios, transfection efficiency generally 
improves with longer PDMAEMA chain length, in the order of E114C44D99 < 
E114C44D213 < E114C44D400.  
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Figure 4.7. In vitro gene transfection efficiency of (A) freshly prepared ECD 
copolymer/pDNA complexes at various N/P ratios in serum-containing medium 
and (B to D) ECD copolymer/pDNA complexes which were incubated for 48 h at 
4 °C and 37 °C, respectively, before feeding COS7 cells for transfection 
efficiency study. Data are presented as mean ± standard deviation (n = 3). ND 
denotes naked DNA. 
Since the ECD/pDNA polyplexes are intended for use in sustained gene 
delivery in the form of supramolecular hydrogel, their stability and tranfection 
efficiency must not be adversely affected by the hydrogel fabrication process which is 
carried out at 4 °C or prolonged incubation at 37 °C as the hydrogel slowly dissolute. 
For this, the temperature effect on luciferase expression level of polyplexes was 
further investigated at 4 °C and 37 °C. ECD /pDNA polyplexes at various N/P ratios 
were firstly incubated for 48 h at 4 °C or 37 °C and then their luciferase expressions 
were examined under standard transfection condition (Figure 4.7B - D)). Generally, 
the transfection efficiencies of the incubated polyplexes formed from E114C44D99 and 
E114C44D400 showed a comparable luciferase expression level to freshly prepared ones. 
For E114C44D213 copolymer, the transgene efficiency was slightly lower in the tested 
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N/P ratio range at the elevated temperature 37 °C when comparing with the newly 
prepared polyplexes. This observation may correlate with the different particle 
aggregation occurring after long time aging [22,52]. 
4.3.4 Cell Viability Assay 
In vitro cytotoxicity of ECD triblock copolymers was evaluated using 
standard MTT assay on COS7 cells. As shown in Figure 4.8, all the cationic polymers 
exhibit dose-dependent cytotoxicity effect. Notably, ECD copolymers with short and 
intermediate PDMAEMA chain lengths present lower toxicity than PEI. The better 
biocompatibility of the two ECD copolymers is evident from their median inhibitory 
concentration (IC50), which is the concentration of gene carrier at which relative cell 
viability decreases to 50% [62]. The IC50 value of PEI is 21 μg/mL while those of 
E114C44D99 and E114C44D213 are 29 and 24 μg/mL, respectively. For the copolymer 
E114C44D400, although it is more toxic than PEI with an IC50 of 13 µg/ml, it can still be 
safely used because the amount required for efficient transfection is lower than PEI 
(Figure 4.8A). In general, cytotoxicity of these cationic polymers is related to their 
high amino group concentration [50,63]. In this work, for short and medium 
PDMAEMA chain length, the introduction of PEG and PCL blocks not only results in 
a lower relative concentration of amino groups, but also improves the 
biocompatibility of the whole copolymers as both PEG and PCL are well known for 
their biocompatibility [64]. The polymer toxicity of E114C44D400, however, is dictated 
by PDMAEMA because of its dominant amount within the copolymer backbone. 
Toxicity of the ECD copolymers increases with increasing PDMAEMA chain length, 
in the order of E114C44D99 < E114C44D213 < E114C44D400, following the trend of 
increasing amino group density (Table 4.1).  
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Figure 4.8. Cell viability assay of ECD triblock copolymers compared with PEI 
(25 kDa) at various concentrations in COS7 cells. Cell viability was determined 
by MTT assay and expressed as a percentage of the control cell culture.  
4.3.5 Characterization of ECD/pDNA Polyplexes Anchored 
Supramolecular Hydrogels  
The optimal transfection N/P ratios of E114C44D400, E114C44D213 and E114C44D99 
copolymers were found to be 7, 20 and 20, respectively. These ratios were herein 
used to prepare each ECD/pDNA polyplexes for subsequent entrapment in α-
CD/PEG supramolecular hydrogels. To better understand the polyplex properties at 
specific N/P ratio and their subsequent interaction with the hydrogel, their particle 
size and surface charge were investigated. As shown in Figure 4.9A, ECD triblock 
copolymers self-assemble into micelles with hydrophobic PCL core and hydrophilic 
MPEG/PDMAEMA corona at copolymer concentration above CMC, as a result of 
their amphiphilicity [50]. The micelles range from 140 to 330 nm in particle diameter. 
Micelles prepared from E114C44D99 are on average 330 nm in diameter and they are 
larger than those prepared from the other two ECD copolymers. This may be caused 
by the poorer dispersability of the block copolymer in water due to relatively low 
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hydrophilic content. The other two copolymer micelles increased in particle size from 
140 to 210 nm with increasing PDMAEMA chain length (Figure 4.9A). Upon 
complexation with pDNA, polyplexes have an average size of 275 to 405 nm, which 
is larger than those of the copolymer micelles, indicating a change in 
hydrophilic/hydrophobic balance of cationic ECD copolymers as a result of 
electrostatic interaction with pDNA. The pDNA complexation process also generated 
very small distribution of particle in the range of 40-100 nm (Figure 4.10B). These 
smaller particles could be some uncomplex polymer micelles. The micelles and 
polyplexes were further characterized by TEM. As shown in Figure 4.10A & B, both 
the micelles and polyplexes have approximately spherical morphology. The sizes 
viewed by TEM are consistent with the results measured on DLS. TEM image in 
Figure 4.10B also confirms the coexistence of the smaller particles in polyplexes 
solution. Figure 4.9B shows zeta potentials of ECD copolymer micelles before and 
after complexation with pDNA. In all cases, zeta potentials decreased from the range 
of 31 ~ 54 mV to 16 ~ 40 mV. This infers that the positive surface charges of the 
micelles, as imparted by PDMAEMA blocks, were greatly shielded by pDNA 
complexation. 
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Figure 4.9. ECD/pDNA polyplexes properties at specific N/P ratios (E114C44D99, 
N/P = 20; E114C44D213, N/P = 20; E114C44D400, N/P = 7). (A) Particle size before and 
after pDNA complexation; (B) Zeta potential before and after pDNA 
complexation. 
Chapter 4: Cyclodextrin-Based Polypseudorotaxane Hydrogels for 




Figure 4.10. ECD copolymer/pDNA polyplexes properties at specific N/P ratios 
(E114C44D99, N/P = 20; E114C44D213, N/P = 20; E114C44D400, N/P = 7). (A) Particle 
size distribution of E114C44D99 before pDNA complexation; (B) Particle size 
distribution of E114C44D99 after pDNA complexation at N/P = 20. The inserted 
graphics show the morphology of particles viewed by TEM. 
ECD/pDNA polyplexes anchored supramolecular hydrogels were prepared 
according to the formulations listed in Table 4.2. PEG with molecular weight of 10 
kDa was selected as the major guest polymer for supramolecular hydrogel formation 
because of its ability to confer reasonable rheological properties to the resultant 
hydrogel and also its easy removal from the body via renal filtration as hydrogel 
dissolute [65]. α-CD is a cyclic oligosaccharide with six D-(+)-glucose units linked 
together in α-1,4 fashion. It possesses a hydrophilic outer surface and a hydrophobic 
inner cavity that participates in host-guest interaction [66]. The host-guest interaction 
between α-CD and higher molecular weight PEG leads to polypseudorotaxane 
formation that in turn induces formation of thixotropic hydrogel [42,54,67]. In this 
article, we deliberately applied a low solid content at 1% PEG and 8% α-CD in the 
hydrogel formulation to highlight the impact and function of ECD/pDNA polyplexes 
towards the gelation process and hydrogel properties. It is also an attempt to push the 
formulation limit towards lower solid loading in this type of supramolecular hydrogel, 
where typical solid contents are greater than 15 wt% [67,68].   
The gelation times for all the hydrogel formulations were estimated by a 
simple vial-tilting method and are listed in Table 4.2. The timing was started 
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immediately after the votexing step until no flow was observed for at least 30 s when 
a vial containing the hydrogel formulation was tilted [54]. The effect of ECD/pDNA 
polyplexes can be clearly seen in Table 4.2 in all the three ECD copolymers used. 
With ECD/pDNA polyplexes, Gel-1, Gel-2 and Gel-3 all gelled faster than Gel-4, a 
control system that comprises only PEG and α-CD. The amount of PEG loading in 
Gel-4 was also deliberately increased to match the total polymer loading in Gel-1, in 
considerations of the effects of solid loading on gelation time as well as ultimate 
hydrogel performance.  
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To understand the role ECD/pDNA polyplexes played in the gelation process, 
one should bear in mind that ECD/pDNA polyplexes are in fact nanoparticles with 
outer corona that are decorated with hydrophilic MPEG of 5 kDa in molecular weight. 
Also, the gelation of these α-CD/PEG supramolecular hydrogels relies on the 
threading of sufficient α-CD molecules onto PEG chains to form 
polypseudorotaxanes that subsequently aggregate into crystalline domains that in turn 
act as physical crosslinks of the hydrogel [54]. Hence, as many of the short MPEG 
chains on the ECD/pDNA polyplexes corona are highly accessible to α-CD 
macrocycles and able to jointly form crystalline polypseudorotaxanes domains with 
α-CD/PEG complexes, these ECD/pDNA poleplexes can then be considered as 
“multi-arm” crosslinkers in the hydrogel formation, which expedite the gelation 
process and lend to improved hydrogel performance. At the same time, the 
hydrophobic PCL core of ECD/pDNA polyplexes could impart greater strength and 
stability to the hydrogel [68].   
The formation of crystalline physical crosslinks in the hydrogels was 
confirmed by X-ray diffraction (XRD) characterization of the hydrogels and their 
lyophilized samples (Figure 4.11). E114C44D99 triblock copolymer shows strong 
diffractions at 2θ = 21.4, 23.4 and 19.1°, indicative of the presence of crystalline PCL 
and PEG (Figure 4.11, curves b & c). However, when it is incorporated into Gel-1, 
the strong diffraction peaks disappeared.  In the diffractogram of lyophilized Gel-1, 
for instance, two diffraction peaks, characteristics of the (210) and (300) diffractions 
from hexagonal lattice of columnar α-CD can be seen at 2θ = 19.8 and 22.6° (Figure 
4.11, curve d) [38]. The presence of this crystalline columnar α-CD structure can also 
be detected in wet hydrogel in XRD at 2θ = 19.8°, albeit with some peak broadening 
(Figure 4.11, curve e), which is not unexpected due to a lower crystallinity in the 
presence of water. This alludes to the role of crystalline columnar α-CD as physical 
crosslinks which drive the self-assembly of hydrogel [69].  
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Figure 4.11. Wide-angle X-ray diffraction patterns of (a) Pure α-CD powder; (b) 
MPEG-PCL-Br; (c) E114C44D213 triblock copolymer; (d) Lyophilized Gel-1; (e) 
Gel-1. The characteristic X-ray diffraction peak of crystalline columnar α-CD at 
2θ = 19.8° and 22.6° are labeled with * and •, respectively. 
Rheological characterizations of the supramolecular hydrogels were further 
performed in dynamic mode to obtain quantitative understanding on the effect of 
ECD/pDNA polyplexes on the hydrogel properties. For a normal α-CD/PEG hydrogel, 
i.e. Gel-4, an oscillatory stress sweep shows that a shear stress of around 37 Pa is 
required to destroy the hydrogel network (Figure 4.12(a)). This is manifested by a 
G′/G″ crossover as the hydrogel was destroyed and turned into liquid-like phase [70]. 
On the contrary, with the anchoring of polyplexes, we see that Gel-2 can withstand a 
shear stress up to 460 Pa before it broke down into liquid-like phase (Figure 4.12(c)). 
Soon after the hydrogels disintegrated, the samples were continually deformed at 
100% deformation for 30 s and had their G′ and G″ monitored over a one hour period 
to follow their structural recovery process, i.e. hydrogel reformation. Such 
understanding on hydrogel reformation is important to ensure that the hydrogels 
prepared are suitable for injectable applications, where hydrogels are greatly 
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deformed during injection and timely reformation is critical. The recovery time of a 
hydrogel is defined as the duration a hydrogel took to reach the G′/G″ crossover point 
from its liquid-like state. As shown in Figure 4.12(d), Gel-2 showed an almost 
instantaneous structural recovery with G′ dominating over G″ soon after removal of 
the high shear stress; but Gel-4 had to take approximately 25 min before its G′ 
dominates over G″ (Figure 4.12(b)). The recovery tests show that the hydrogels are 
thixotropic, exhibiting time dependant viscoelastic behavior as a result of gradual 
structural recovery [71]. The complete rheological data obtained from oscillatory 
stress sweep measurements for all four gels are presented in Table 4.2. Hydrogels 
(Gel-1, Gel-2 and Gel-3) comprising of ECD/pDNA polyplexes demonstrated high G′ 
and high yield point in comparison to Gel-4. In other words, the presence of 
ECD/pDNA polyplexes has markedly improved the hydrogels’ stiffness (higher G′) 
and strength (higher yield point) [54]. Such improvements, including faster hydrogel 
recovery, can be attributed to the “multi-arm” crosslinking afforded by ECD/pDNA 
polyplexes, which lead to a more extensive and stronger hydrogel network. 
Essentially, the rheological data have verified the important role of ECD/pDNA 
polyplexes in the formation of stronger polypseudorotaxane hydrogels with excellent 
recovery characteristics. This has very positive and important bearings on injectable 
applications. 
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Figure 4.12. (a) Oscillatory stress sweep measurement of Gel-4 at 25 °C and 
constant ω = 1 rad/s. (b) Oscillatory time sweep measurement of Gel-4 at 25 °C 
and constant shear stress (σ = 5 Pa) soon after the hydrogel was deformed at 
100% deformation for 30 s. (c) and (d) are oscillatory stress and time sweep 
measurements of Gel-2, respectively, performed under identical conditions as for 
Gel-4. G′ and G″ are represented by open and closed symbols, respectively. 
4.3.6 In-vitro DNA Release Study 
With pDNA entrapped within the polypseudorotaxane hydrogels, their DNA-
releasing behavior of were assessed through hydrogel dissolution study. In hydrogels 
that contain ECD/pDNA polyplexes, sustained release of DNA up to 5-6 days was 
achieved. When the same amount of pDNA (70 µg) was simply encapsulated in α-
CD/PEG hydrogel (Gel-4) in its naked form, a poorer sustained release up to 3 days 
was observed, as shown in Figure 4.13. In all cases, the initial DNA release profiles 
are rather linear without significant burst release and the hydrogels were completed 
eroded upon 100% DNA release. This suggests that the DNA release is not diffusion-
controlled. On the other hand, it is presumably controlled by the gradual erosion of 
the hydrogels through de-threading of the α-CD from PEG and MPEG chains when 
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the hydrogels were exposed to aqueous environment [72]. The longer release profiles 
for Gel-1, Gel-2 and Gel-3 as compared to Gel-4 can again be attributed to their better 
stability against dissolution that arises from the “multi-arm” crosslinking afforded by 
ECD/pDNA polyplexes. The slightly faster sustained release of Gel-1as compared to 
Gel-2 and Gel-3 is due to its compositional inhomogeniety as a result of poor 
dispersability of corresponding polyplexes during hydrogel fabrication. Regions 
within its hydrogel matrix that are lower in ECD/pDNA polyplexes are more 
susceptible to erosion and thus constituting the weaker links that lead to faster 
hydrogel erosion than the more homogenous Gel-2 and Gel-3. In comparison to other 
PEG hydrogel systems reported in the literature, the ECD/pDNA containing 
hydrogels in this study are more superior in terms of higher DNA loading efficiency 
and longer DNA release duration [30,38,73]. In addition, pDNA released from the 
polypseudorotaxane hydrogels was found to be in its intact polyplex form. This can 
be seen from Figure 4.6C, where the pDNA-cotaining released media collected at 
various time points were subjected to agarose gel electrophoresis with or without 
heparin pre-treatment. For Gel-1, Gel-2 and Gel-3, the presence of pDNA can only be 
detected with heparin pre-treatment. One can thus infer that pDNA released from the 
hydrogels are in the form of polyplexes. In the case of Gel-4, as expected, pDNA 
released can be identified to the naked pDNA. The hydrogel weight remaining 
profiles as a function of incubation time at pH 7.4 and 37 °C was obtained to evaluate 
the progress of the gel dissociation (Figure 4.14). All gels were experiencing a steady 
mass loss with the increasing incubation period. This may be due to the surface 
erosion, occurring through the gradual dethreading of the α-CD from PEG and 
MPEG chains when the hydrogels were immersed in a large quantity of PBS buffer 
solution [44,69]. More interestingly, the hydrogel erosion profiles correlate well with 
the pDNA released content. The results indicate that the pDNA release from the 
hydrogels is mainly controlled by the gel disassociation mechanism. 
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Figure 4.13. In vitro release profiles of encapsulated pDNA from ECD/pDNA 
anchored supramolecular hydrogels.  
 
Figure 4.14. Supramolecular hydrogels disassociation profiles as a function of 
incubated time at pH 7.4 and 37 °C.  
From the experimental results presented thus far, it becomes evident that the 
sustained DNA release achieved in the ECD/pDNA polyplex anchored 
polypseudorotaxane hydrogels should follow the mechanism as outlined in Figure 4.1. 
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ECD copolymers play a central role in condensing the pDNA into polyplexes, 
anchoring the polyplexes within a polypseudorotaxane hydrogel and lastly deliver the 
pDNA in the form of intact polyplex. The α-CD/PEG polypseudorotaxane hydrogel, 
on the other hand, provides an erodable matrix with suitable rheological characteristic 
to sustain the release of ECD/pDNA polyplexes. 
4.3.7 Sustained Transfection Efficiency Study 
The bioactivity of pDNA polyplexes released from the supramolecular 
hydrogels at various time points was further investigated by in vitro gene transfection 
experiment. Polyplexes freshly prepared at their optimal N/P ratios were also used as 
controls. Figure 4.15 shows the transfection efficiency evaluated by luciferase assay. 
As presented, the transfection efficiency mediated by the E114C44D400 condensed 
polyplexes that were released over a 6-day period from Gel-3 is the highest among all 
other ECD copolymers. Notably, the efficiency is comparable to those of freshly 
prepared polyplexes and higher than that of PEI at its optimal N/P ratio of 10. The 
sustained transgene expression evaluated on polyplexes released from Gel-1 also 
shows comparable efficiency to the freshly prepared PEI and E114C44D99/pDNA 
polyplexes at specific N/P ratios of 10 and 20, respectively. However, E114C44D213 
condensed polyplexes that were released from Gel-2 exhibitted a slightly lower 
luciferase expression than its freshly prepared polyplexes. This may be due to an 
excessive hydrogel-polyplex interactions that hinders the release of polyplexes for 
subsequent cellular intake [38]. Indeed, among all the ECD/pDNA polyplexes, 
E114C44D213/pDNA polyplexes have the strongest interaction with the 
polypseudorotaxane hydrogel matrix, as evidenced by the fastest gelation time and 
largest yield point in Gel-2 (Table 4.2).  Such strong hydrogel-polyplex interactions 
can be attributed to the intermediate PDMAEMA chain length in E114C44D213 that is 
just right to allow uniform copolymer dispersion during hydrogel formation without 
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shielding MPEG on the polyplexes from α-CD threading. Nevertheless, these 
transfection experiments do confirm the bioactivity of the released ECD/pDNA 
polyplexes and lend support to the application of these hydrogel systems in sustained 
gene delivery. 
In addition, standard MTT measurements were also used to evaluate the 
cytotoxicity of the ECD/pDNA polyplexes released at various times (Figure 4.16). 
Comparing the toxicity over the course of DNA release, pDNA polyplexes collected 
on the first day from all hydrogels are more toxic than those released later. The higher 
toxicity in the initial stage of DNA release could be due to remnant ECD copolymers 
that are not complex to pDNA. Cell viability improves as their concentration 
diminishes over time. The same reason could be used to understand the higher 
toxicity of E114C44D99/pDNA polyplexes over the 5-day pDNA release as high 
polymer concentration is used in the culture media to reach an N/P ratio of 20. 
However, such toxicity issue is not expected to happen in an in vivo setting where the 
released pDNA polyplexes will either be instantly taken up by the cells in the 
surrounding tissue, or will be diluted by body fluid and cleared by lymphatic system 
[30]. Cell viability for the other two groups from Gel-2 and Gel-3 were around 80% 
from day 2 onwards. These results suggest that the ECD/pDNA polyplexes released 
from the polypseudorotaxane hydrogels have no significant cytotoxicity. 
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Figure 4.15. Sustained gene transfection efficiency of pDNA polyplexes released 
from supramolecular hydrogels at various times in comparison with freshly 
prepared PEI and ECD/pDNA polyplexes at their optimal N/P ratios. 
 
 
Figure 4.16. Cell viability assay of pDNA polyplexes released from 
supramolecular hydrogels at various time. 
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4.4 Conclusions 
A series of MPEG-PCL-PDMAEMA (ECD) triblock copolymers with short, 
intermediate and long cationic PDMAEMA block length were synthesized through a 
combination of ROP and ATRP techniques. Their molecular and structural properties 
were characterized by EA, GPC and NMR. ECD copolymers form micelles in water 
and their micelles condense pDNA into polyplexes with diameter in the range of 275 
- 405 nm and positive zeta potential of 16 - 40 mV at N/P ratios of 7 to 20. At optimal 
N/P ratio of each polymer, the ECD/pDNA polyplexes function as “multi-arm” 
physical crosslinkers in the formation of polypseudorotaxane hydrogels. They 
facilitated hydrogel formation in shorter time and improved rheological properties of 
the hydrogels in terms of higher G′, larger yield point and instantaneous hydrogel 
recovery. Furthermore, the resultant hydrogels were able to release the pDNA in the 
form of stable polyplexes and in a sustained manner. More importantly, in vitro gene 
transfection results showed that the pDNA released at various time points have good 
bioactivity. All these findings indicate that the bioactive pDNA polyplexes anchored 
polypseudorotaxane hydrogels can be potentially used as sustained gene delivery 
carrier. 
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CHAPTER 5 FUNCTIONALIZATION OF LIGNIN 
THROUGH ATRP GRAFTING OF POLY[(2-
DIMETHYLAMINO)ETHYL METHACRYLATE] 
FOR GENE DELIVERY APPLICATION  
5.1 Introduction  
As the issues of environmental pollution and resource crisis are gaining more 
and more attentions from the public and scientific community, the reusing of waste 
and the development of renewable resources have become one of the key research 
topics in the world. Lignin, one of the major renewable biomass, is a natural polymer 
commonly found in cell walls of wood and annual plants, which together with 
hemicelluloses acts as a cementing matrix of cellulose fibers in the woody structures 
of plants. Lignin is one of the major components of wood and annual plants, making 
up 24 – 35 % of over-dry weight of softwoods and 17 – 25 % of hardwoods. After 
cellulose, lignin is the most abundant natural non-fossil organic carbon source on 
Earth, and regenerates at a rate of 50 billion tons per year [1]. As a main by-product 
from pulp and paper industry, the global output of lignin is over 50 million tons per 
year. However, more than 95% of the output had been disposed or incinerated as 
wastes [2]. Much of this can be attributed to its complex irregular macromolecular 
properties.  
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In the last decade, a growing interest arises in utilizing lignin to develop 
functional materials. Lignin was blended with hydrophilic polymers to improve its 
processability and themal properties to stabilize plastics [3-6]. It has also been used 
for gel development [7-9]. However, there is no report in using it for non-viral gene 
delivery. At present, research of lignin-based materials is still at very early stage and 
their applications are quite limited. Atom transfer radical polymerization (ATRP) is a 
recently developed ‘living’ radical polymerization method, involving a copper 
halide/nitrogen-based ligand catalyst [10]. The method does not require stringent 
experimental conditions, as in the cases of cationic and anionic polymerization. This 
controlled radical polymerization technique allows for the polymerization and block-
copolymerization of a wide range of functional monomers in a controlled fashion, 
yielding polymers with narrowly dispersed molecular weights, pre-determined by the 
concentration ratio of the consumed monomer to initiator.  
The general goal of this work is to utilize the abundant natural biomass 
resource of lignin as starting material to create functional polymeric materials with 
great added values. Briefly, we have developed a synthesis strategy to convert lignin 
into a new type of gene delivery system in an efficient way. This includes the 
modification of lignin into a lignin-based macroinitiator, and grafting of cationic 
Poly[(2-dimethylamino)ethyl methacrylate] (PDMAEMA) arms onto the lignin core 
via ATRP technique. To evaluate their performance as gene delivery vectors, in vitro 
transfection and luciferase assay was carried out in different cell lines. It was 
demonstrated that the lignin-PDMAEMA copolymers would be a new type of gene 
delivery system.  
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5.2 Experimental Section  
5.2.1 Materials  
Lignin, alkali (Mn = 5000, Mw = 2,8000), anhydrous N,N’-
dimethylacetamide (99.8%, DMA), 2-bromoisobutyryl bromide (98%), acetic 
anhydride(99.5%), N,N’-dimethylformamide ( DMF, AR grade), pyridine (99.8%), 
CuBr(98%), 1,1,4,7,10,10-hexamethyltriethylenetetramine (97%, HMTETA), were 
obtained from Sigma-Aldrich. Ethyl ether (AR grade), 1.4-dioxane (AR grade), 
tetrahydrofuran (AR grade, THF), anhydrous tetrahydrofuran (≥99.9%, anhydrous 
THF) were purchased from Fisher. 2-(Dimethylamino) ethyl methacrylate 
(DMAEMA) was purchased from Merck. DMSO-d6, acetone-d6, D2O and DCl, which 
were used as solvents in NMR measurements, were supplied by Cambridge isotope 
laboratories. The Qiagen kit and Luciferase kit were purchased from Qiagen and 
Promega, respectively. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT), penicillin, and streptomycin were obtained from Sigma. 
5.2.2 Synthesis Methods 
Quantification of Total Hydroxyl Content in Lignin via 
Acetylation. Before modification of lignin with 2-bromoisobutyryl bromide, the 
total content of hydroxyl groups including aliphatic and phenolic ones was 
determined. Briefly, 400 mg of dried lignin (0.08 mmol) was dissolved in 16 mL of 
pyridine/acetic anhydride (1:1, v/v). The reaction solution was stirred for 48 h under 
nitrogen at room temperature. After that, the reaction solution was added dropwise 
with stirring to 300 mL of ice-water. The precipitated acetylated lignin was collected 
by centrifugation, washed 3 times with ice-water 100 mL, freeze-dried and further 
dried under vacuum at 50 °C. 
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By comparing the 1H NMR result of acetylated lignin with that of external 
reference (ethyl acetate), the content of hydroxyl groups in lignin was calculated to be 
37.05 mole of –OH in one mole of lignin (aromatic –OH 40.2%, aliphatic –OH 
59.8% ).  
Synthesis of Lignin-Based Macroinitiators. Two examples for the 
preparation of lignin-based macroinitiators with final modification degree (MD) of 
3.0% and 100%, respectively, were provided as below: 
Synthesis of LnMI-a (MD 3.0%). Lignin (5.0g, 1mmol, contains -OH 
37.05 mmol) was weighed into a reaction flask, and dried at 100 oC under vacuum for 
one day.  Then the dried lignin was cooled down to room temperature under nitrogen 
atmosphere. Subsequently, anhydrous DMA (50 mL) was injected into the flask to 
dissolve the lignin under rapid stirring.  Then 15 mL of anhydrous DMA containing 
2-bromoisobutyryl bromide (5.679 g, 24.7 mmol, 3.05 mL) was added dropwise into 
the lignin solution under rapid stirring during a period of 1h. The reaction mixture 
was continued to stir for 2 days at room temperature. After that, the reaction mixture 
was precipitated with 1L of ether. The tan gel-like precipitate, which was usually 
sticked to the bottom of container, was re-dissolved into DMF (30 mL) and the 
solution was then precipitated with 1L of distilled water. The brown powder of lignin 
macroinitiator was collected by centrifugation, washed 2 times with 50 ml of distilled 
water, and freeze dried. Yield 3.94 g (45.4%). 1H NMR (DMSO-d6) of LnMI-a: δ 
(ppm) 1.4-2.2 (-CH3 of initiation group), 3.5-4.3 (-CH3O-), 6.0-8.0 (aromatic protons 
of lignin). 
Synthesis of LnMI-g (MD 100.0%). Lignin (5.0g, 1mmol, contains -OH 
37.05 mmol) was weighed into a reaction flask, and dried at 100 oC under vacuum for 
one day.  Then the dried lignin was cooled down to room temperature under nitrogen 
atmosphere. Subsequently, anhydrous THF (160 mL) was injected into the flask to 
dissolve the lignin under rapid stirring.  Then TEA (9.997g, 98.8 mmol, 13.77 mL) 
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was added into lignin solution. After that, 20 mL of anhydrous THF containing 2-
bromoisobutyryl bromide (25.56 g, 111.2 mmol, 13.74 mL) was added dropwise into 
the lignin solution under rapid stirring during a period of 1h. The reaction mixture 
was continued to stir for 2 days at room temperature. After that, the reaction mixture 
was precipitated with 1L of ether. The tan gel-like precipitate, which was usually 
sticked to the bottom of container, was re-dissolved into DMF (30 mL) and the 
solution was then precipitated with 1L of distilled water. The brown powder of lignin 
macroinitiator was collected by centrifugation, washed 2 times with 50 ml of distilled 
water, and freeze dried. Yield 8.92 g (84.8%). 1H NMR (DMSO-d6) of LnMI-g: δ 
(ppm) 1.4-2.2 (-CH3 of initiation group), 3.5-4.3 (-CH3O-), 6.0-8.0 (aromatic protons 
of lignin). 
Synthesis of Lignin-PDMAEMA Graft Copolymer via ATRP. One 
example for preparation of lignin-PDMAEMA graft copolymer with by using lignin 
based macroinitiator LnMI-a (MD 3.0%) was provided as below: 
Lignin-PDMAEMA graft copolymer LnPDMAEMA-01. Lignin-
macroinitiator LnMI-a (MD = 3.0%) (251.3 mg, 0.06 mmol-Br) and DMAEMA 
(0.943 g, 6 mmol, 1.011ml) were added into a dry flask. The flask was sealed with a 
septum and subsequently purged with dry nitrogen for several minutes. Then, 
HMTETA (13.83 mg, 0.06 mmol, 16.32 µl) in 3 mL of thoroughly degassed DMF 
was injected with a degassed syringe. The mixture was stirred at r.t. and purged with 
dry nitrogen for 40 min. Last, CuBr (86.07 mg, 0.06 mmol) was added and the 
mixture was purged with dry nitrogen for another 10 min at r.t. The mixture was then 
heated at 65 oC in an oil bath. After 2 days, the experiment was stopped by opening 
the flask and exposing the catalyst to air. The final tan mixture was diluted with THF 
and passed through a short neutral Al2O3 column with THF as eluent to remove 
copper catalyst. The resulting eluate solution was concentrated to ca. 10 mL, and 
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precipitated with 900 mL hexane. The brown product was collected by centrifugation, 
washed with hexane, and dried under vacuum at 40 oC. Yield 420 mg (23.0 %). 
The ATRP conditions for synthesis of other lignin-PDMAEMA copolymer 
are similar to those for LnPDMAEMA-01, and the difference will be lignin based 
macroinitiator, molar ratio of monomer/-Br and solvent etc. 
5.2.3 Characterization Methods 
5.2.3.1 Chemical Characterization Methods 
1H NMR Spectroscopy. 1H NMR spectra were recorded on a Bruker AV-
400 NMR spectrometer at 400 MHz at room temperature. The 1H NMR 
measurements were carried out with an acquisition time of 3.2 s, a pulse repetition 
time of 2.0 s, a 30° pulse width, 5208 Hz spectral width, and 32 K data points. 
Chemical shifts were referenced to the solvent peak (δ= 4.70 ppm for D2O). The 
elemental compositions of samples were tested by using a carbon, hydrogen, nitrogen, 
and sulfur (CHNS) instrument (Flash EA 1112, CE Instruments, ThermoFisher 
Scientific). Around 2 mg of dried samples were used for test in automatic mode. PEI 
(25 kDa) was tested before other samples to make sure the accuracy of the experiment 
result. 
Dynamic light scattering and zeta-potential measurements. 
Measurements of particle size and zeta potential of the complexes were performed 
using a Zetasizer Nano ZS (Malvern Instruments, Southborough, MA, USA) with a 
laser light wavelength of 633nm at a 173° scattering angle. Complex solutions (100 
µL) containing 3 µg of pDNA (pRL-CMV) were prepared at various N/P ratios 
ranging from 2 to 30. The mixture was vortexed for 20 s, incubated for 30 min at 
room temperature and diluted in 1mL of the distilled water before being analyzed on 
the Zetasizer. The size measurement was performed at 25 °C in triplicate. The 
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deconvolution of the measured correlation curve to an intensity size distribution was 
accomplished using a nonnegative least squares algorithm. The Z-average 
hydrodynamic diameters of the particles were given by the instrument. The Z-average 
size is the intensity weighted mean diameter derived from a cumulants or single-
exponential fit of the intensity autocorrelation function. The zeta potential 
measurements were performed using a capillary zeta potential cell in automatic mode. 
5.2.3.2 Biological Characterization Methods 
(a) Plasmid 
The plasmid used was pRL-CMV (Promega, USA), encoding Renilla 
luciferase, which was originally cloned from the marine organism Renilla reniformis. 
The plasmid DNA was amplified in E. coli and purified according to the supplier’s 
protocol (Qiagen, Hilden, Germany). The quantity and quality of the purified plasmid 
DNA was assessed by optical density at 260 and 280 nm and by electrophoresis in 
1% agarose gel. The purified plasmid DNA was resuspended in TE buffer (10mM 
Tris-Cl, pH 7.5, 1mM EDTA) and kept in aliquots at a concentration of 0.5 mg/mL. 
(b) Cells and media 
All cell lines were purchased from ATCC (Rockville, MD). COS7, Hela and 
MDA-MB-231 (human breast cancer cells) cells were maintained in Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% heat-inactivated fetal 
bovine serum, 100 units/mg penicillin, 100 µg/mL streptomycin at 37 °C and 5% CO2. 
Opti-MEM reduced serum medium, DMEM medium was purchased from Gibco BRL 
(Gaithersburg, MD). 
(c) Gel Retardation Assay 
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The binding ability of Lignin-PDMAEMA copolymers to pDNA was 
examined by gel electrophoresis. After adding 10 × loading buffer with polyplex 
solutions, samples were loaded on a 0.8% agarose gel stained with 0.5 mg/mL 
ethidium bromide. The gels were run in 1 × TAE buffer (40 mM Tris-acetate, 1 mM 
EDTA) at 100 V for 30 min in a Sub-Cell system (Bio-Rad Laboratories, CA). DNA 
bands were visualized with a UV lamp on GelDoc system (Synoptics Ltd., UK). 
 (d) Cell viability assay 
COS7, MDA-MB-231 and Hela cells were cultured in DMEM medium 
supplemented with 10% FBS at 37 °C, 5% CO2, and 95% relative humidity. For cell 
viability assay, the cells with concentration of 10,000 cells/well were seeded into 96-
well microtiter plates (Nunc, Wiesbaden, Germany). After 24 h, culture media were 
replaced with serum-supplemented culture media containing serial dilutions of 
sample and the cells were incubated for 24 h. Then 10 µL sterile filtered MTT (5 
mg/ml) stock solution in PBS was added to each well, reaching a final concentration 
of 0.5 mg MTT/mL. After 5 h, unreacted dye was removed by aspiration. The 
formazan crystals were dissolved in 100 µL/well DMSO and the absorbance was 
measured by using a microplate reader (Spectra Plus, TECAN) at a wavelength of 
570 nm. Six wells were treated together as a group. The relative cell growth (%) 
related to control cells cultured in media without polymer was calculated by 
[A]test/[A]control × 100%.  
(e) In vitro transfection and luciferase assay 
Transfection studies were performed in COS7, MDA-MB-231 and Hela cells 
using the plasmid pRL-CMV as reporter gene. In brief, 24-well plates were seeded 
with cells at a density of 5×104/well 24 h before transfection. The sample/DNA 
complexes at various N/P ratios were prepared by adding different samples into DNA 
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solutions dropwise, followed by vortexing and incubation for 30 min at room 
temperature before transfection. At the time of transfection, the medium in each well 
was replaced with 300 µL reduced-serum medium or normal complete DMEM 
medium. The complexes were added into the transfection medium and incubated with 
cells for 4 h under standard incubator conditions. After 4 h, the medium was replaced 
with 500 µL of fresh medium supplemented with 10% FBS, and the cells were further 
incubated for an additional 20 h under the same conditions, resulting in a total 
transfection time of 24 h. Cells were washed with PBS twice, lysed in 100 µL of cell 
culture lysis reagent (Promega, Cergy Pontoise, France). The luciferase activity in 
cell extracts was measured using a luciferase assay kit (Promega) on a single-well 
luminometer (Berthold lumat LB9507, Germany) for 10 sec. The relative light units 
(RLU) were normalized against protein concentration in the cell extracts, which was 
measured using Commassie PlusTM Protein Assay Reagent (Pierce). Absorption was 
measured on a microplate reader (Spectra Plus, TECAN) at 595 nm and compared to 
a standard curve calibrated with BSA. Results are expressed as relative light units per 
milligram of cell protein lysate (RLU/mg protein).  
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5.3 Results and Discussion 


















































































 Figure 5.1. Synthetic Procedures for (A) Lignin-Based Macroinitiator and (B) 
Lignin-Based Graft Copolymer via ATRP. 
Lignin is a cross-linked racemic macromolecule with molecular masses in 
excess of 10,000 Da. It is relatively hydrophobic and aromatic in nature. The basic 
chemical phenylpropane units of lignin (primarily p-hydroxy phenol, guaiacyl, and 
syringyl) are bonded together by a set of linkages to form a very complex matrix. 
Besides a larger number of aromatic rings, this matrix comprises a variety of 
functional groups, such as hydroxyl (alcohol and phenol), methoxyl and carbonyl, 
which impart a high polarity to the lignin macromolecule[11]. 
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For the preparation of a lignin-based macroinitiator, initiator fragments, -
OCO-C(CH3)2Br were introduced into the lignin backbone via the esterification of the 
alcohol and/or phenol functional groups on the lignin with 2-bromoisobutyryl 
bromide according to our previously reported method [12, 13]. In this work, a series 
of lignin-based macroinitiators with modification degree (MD) of 3.0 – 100 % were 
synthesized (Figure 5.1A). Selected synthesis conditions and characterization results 
for these macroinitiators were summarized in Table 5.1 and 5.2. 
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macroinitiator bMn calculated 




a Calculated according to 1H NMR by comparing the integration of the proton signals due to 
initiation site to those of 100% modified macroinitiator, LnMI-g; 
b Calculated according to MD. 
1H NMR spectra for macroinitiators LnMI-f (MD = 70.8%) and LnMI-g (MD 
= 100%) were given here as examples (Figure 5.2). 
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Figure 5.2. 1H NMR characterization result for lignin based macroinitiators (d6-
DMSO, 400 MHz, r.t.). 
5.3.2 Synthesis and Characterizations of Lignin-PDMAEMA Graft 
Copolymer via ATRP 
ATRP of DMAEMA using lignin-based macroinitiator was carried out under 
a nitrogen environment in the presence of copper(I) bromide as catalyst and 
HMTETA as ligand according to our previously reported method (Figure 5.1B) 
[12,13]. It was found that the lignin-based macroinitiator with different modification 
degree (MD) has different solubility in organic solvent. So, in this study, different 
solvent was chosen as ATRP reaction medium depending on the macroinitiator used. 
For example, initiator LnMI-a with a low MD of 3.0% can only well dissolved in 
DMF, so DMF was chosen as solvent for synthesis of copolymer LnPDMAEMA-01 
and 02. While for other initiators with MD > 3.0%, dioxane or THF can be used as 
ATRP solvents. In this work, total 20 lignin-PDMAEMA copolymers were prepared. 
The polymerization conditions and characterization results were summarized in Table 
5.3 and 5.4, respectively.  
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59.02 d65 ℃13100:1:1:1LnPDMAEMA-13 










/2 d65 ℃13100:1:1:1 LnPDMAEMA-08*
25.82 d65 ℃13100:1:1:1 LnPDMAEMA-07 
46.32 d65 ℃6.550:1:1:1 LnPDMAEMA-06
42.42 d65 ℃3.930:1:1:1 LnPDMAEMA-05 
38.12 d65 ℃2.620:1:1:1 LnPDMAEMA-04 





16.52 d65 ℃10200:1:1:1LnPDMAEMA-02 








Initiator Lignin-PDMAEMA copolymer 
 
* LnPDMAEMA-08, 09, 19 were treated with dilute HCl aqueous solution. 
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a Calculated according to N%. 
LnPDMAEMA-08, 09, 19 were treated with dilute HCl aqueous solution. 
After grafting PDMAEMA arms onto lignin backbone via ATRP, the final 
lignin-PDMAEMA copolymer is very soluble in common organic solvent such as 
THF, acetone and ethanol etc. A typical 1H NMR spectrum for copolymer 
LnPDMAEMA-20 (from initiator LnMI-c0, [M]0/[I]0 = 70)  in d6-acetone was given 
here as example (Figure 5.3). The signals due to aromatic protons of lignin backbone 
and the protons of DMAEMA unit were clearly observed, while the water solubility 
of the final copolymers depended on the composition of the copolymer. Basically, the 
copolymers with more grafted DMAEMA units will have better water solubility. 
Further study showed if the copolymers were treated with dilute HCl aqueous 
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solution, its water solubility will be greatly improved. For example, the copolymer 
LnPDMAEMA-05 (from initiator LnMI-c, [M]0/[I]0 = 30) did not well dissolved in 
water. However, it was very soluble in dilute HCl aqueous solution (pH 4.0). The 1H 
NMR spectra for copolymer LnPDMAEMA-05 in D2O and D2O containing DCl 
(0.05 mol/L) were seen in Figure 5.4. It can be seen that in D2O the peaks due to 
DMAEMA units were weak and broad; while in and D2O containing DCl (0.05 mol/L) 
all of the peaks were well resolved.  
 
Figure 5.3. 1H NMR Characterization result for lignin-PDMAEMA graft 
copolymer LnPDMAEMA-20 (d6-DMSO, 400 MHz, r.t.). 
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Figure 5.4. 1H NMR Characterization results for lignin-PDMAEMA graft 
copolymer LnPDMAEMA-05 in D2O and D2O containing DCl (0.05 mol/L), 
respectively. 
5.3.3 pDNA Condensation Capability 
The DNA condensation induced by a cationic polymer is a prerequisite for 
successful gene delivery [14]. As was well known, lignin itself has no DNA 
condensation ability. When grafted with PDMAEMA arms, the lignin-PDMAEMA 
copolymers showed good DNA condensation ability. Their condensation capabilities 
were evaluated by agarose gel electrophoresis, particle size and zeta potential 
measurements. Polyplexes were prepared by electrostatic interaction between 
positively charged lignin-PDMAEMA copolymers and negatively charged pDNA at 
various N/P ratios. As shown in Figure 5.5, the condensation capability of lignin-
PDMAEMA copolymer was mainly dependent on its N content, the higher the N 
content, the better the condensation ability. For example, LnPDMAEMA-03 (N = 
4.97%) can fully retard the pDNA movement at N/P ratio of 4, while in the case of 
LnPDMAEMA-17 (N= 8.34%), N/P ratio of 1.5 is enough. This value is close to that 
of PEI, which is 2.  
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Figure 5.5. Electrophoretic mobility of pDNA in the polyplexes formed with  (A) 
LnPDMAEMA-03, (B) LnPDMAEMA-05, (C) LnPDMAEMA-06, (D) 
LnPDMAEMA-11, (E) LnPDMAEMA-12, (F) LnPDMAEMA-14, (G) 
LnPDMAEMA-16, (H) LnPDMAEMA-17, (I) LnPDMAEMA-20 and  (J) PEI 
(25 kDa) at various N/P ratios. 
Figure 5.6 shows the particle size and zeta potential of LnPDMAEMA 
copolymer/pDNA complexes in comparison with PEI/pDNA at various N/P ratios. As 
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shown in Figure 5.6A, all the selected LnPDMAEMA copolymers could efficiently 
compact pDNA into small nanoparticles. The particle size decreased with the increase 
of the N/P ratio until the N/P ratio was 10 and then remained in the range of 80 -130 
nm thereafter. The polydispersity indexes of all samples mostly range from 0.1 to 0.2, 
indicating a low to moderate levels of polydispersity. With the increase of N/P ratio, 
the surface net charge of LnPDMAEMA/pDNA complex increased and stabilized at 























































Figure 5.6. Particle size (A) and zeta potential (B) of the complexes between 
lignin-PDMAEMA copolymers and pDNA in comparison with PEI/pDNA at 
various N/P ratios. 
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5.3.4 Cytotoxic Effect of Lignin-PDMAEMA Copolymers on MDA-MB-
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Figure 5.7. Cell viability assay of lignin-PDMAEMA copolymers in MDA-MB-
231 (A) and COS7 (B) cells in comparison with that of PEI (25 kDa). Data 
represent mean ± standard deviation (n = 6). 
Figure 5.7 shows the in vitro cytotoxic effect of lignin-PDMAEMA 
copolymers in MDA-MB-231 (A) and COS7 (B) cells in comparison with PEI (25k, 
branched). Generally, the cytotoxicity of lignin-PDMAEMA copolymers increases as 
the N content increases in both MDA-MB-231 and COS7 cells. For example, 
LnPDMAEMA-03 (N = 4.97%) showed the lowest toxicity among all the selected 
copolymers, while LnPDMAEMA-18 (N = 8.34%) gave the highest toxicity (even 
higher than PEI) (Figure 5.7A). In addition, the modification degree (MD) of lignin-
based macroinitiator and the number of DMAEMA unit per arm also affect the 
cytotoxicity of lignin-PDMAEMA copolymers. It seems that the lower the MD and 
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DMAEMA number per arm, the lower the cytotoxicity, and MD plays a more 
important role than the DMAEMA number per arm, such as LnPDMAEMA-11 (MD 
= 5.2%, DMAEMA number per arm = 71.2) and LnPDMAEMA-19 (MD = 100%, 
DMAEMA number per arm = 6.0). The estimated IC50 for LnPDMAEMA-12, 
LnPDMAEMA-14 and LnPDMAEMA-20 in MDA-MB-231cells are 18 μg/mL, 68 
μg/mL and 24 μg/mL respectively. While in COS7 cells, their cytotoxicity are much 
lower (96 μg/mL for LnPDMAEMA-12, 126 μg/mL for LnPDMAEMA-14 and 84 
μg/mL for LnPDMAEMA-20). This may attribute to the different tolerance of these 
two cell lines to toxic drug.  
5.3.5 In Vitro Transfection Efficiency of Lignin-PDMAEMA Copolymers 
In vitro transfection and luciferase assay was carried for these lignin-
PDMAEMA copolymers. It was found that the gene transfection efficiency of these 
copolymers depends greatly on the modification degree (MD) of lignin-based 
macroinitiators and the chain length of PDMAEMA arms.  
For lignin macroinitiator LnMI-c (MD 27.6%), all copolymers synthesized 
from this initiator with different arm length, i.e. copolymers LnPDMAEMA-03 to 07 
(nitrogen content, N%: 4.97-7.80%), have lower gene transfection efficiency than 
commercial available branched PEI (25 kDa) in both Hela and Cos-7 cell line (Figure 
5.8). Generally, the gene transfection efficiency increased with the chain length in 
this case. 
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Figure 5.8. In vitro gene transfection efficiency of the complexes of 
LnPDMAEMA (03-07) / pDNA in comparison with PEI/DNA in Hela (A) and 
COS7 (B) cells. Data represent mean ± standard deviation (n = 3).   
For lignin macroinitiator LnMI-c0 (MD 20.2%), a typical copolymer from 
this initiator, LnPDMAEMA-20 with N% of 7.57%, has comparable gene 
transfection efficiency to PEI in Cos-7 cell line (Figure 5.9). 
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Figure 5.9. Transfection efficiency of LnPDMAEMA-20 synthesized from 
initiator LnMI-c0 (MD 20.2%) in COS7 cells. Data represent mean ± standard 
deviation (n = 3).   
Further, for lignin initiator LnMI-d (MD 36.7%) and LnMI-e (MD 44.4%), 
their copolymers with N% of 7.28 (LnPDMAEMA-12) and 6.05% (LnPDMAEMA-
14) respectively, have comparable (in cell lines of COS7 and Hela) and obvious 
higher (in cell line MDA-MB-231) gene transfection efficiency than PEI under serum 
condition (Figures 5.10). For example, at N/P of 40 in MB231 cells, the gene 
transfection efficiency of LnPDMAEMA-12 and LnPDMAEMA-14 are ca. 10 and 
100 higher than that of PEI, respectively.  
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Figure 5.10. Transfection efficiency of LnPDMAEMA-12 to LnPDMAEMA-16 
in COS7 (A), Hela (B) and MDA-MB-231 (C) cells. Data represent mean ± 
standard deviation (n = 3). 
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5.4 Conclusions 
In summary, we have designed a novel lignin-PDMAEMA gene delivery 
system synthesized by atom transfer radical polymerization (ATRP). A series of 
lignin-based macroinitiators (LnMI-a to g) with different modification degree (MD) 
were synthesized (MD = 3.0 -100%) in an easy and efficient way. These 
macroinitiators were successfully used in grafting cationic PDMAEMA arms onto 
lignin backbone via ATRP. In vitro gene transfection efficiency of these copolymers 
depends greatly on the modification degree (MD) of lignin-based macroinitiators and 
the chain length of PDMAEMA arms. Copolymers LnPDMAEMA-12 with N% of 
7.28% synthesized from lignin initiator LnMI-d (MD 36.7%) and LnPDMAEMA-14 
with N% of 6.05% synthesized from lignin initiator LnMI-e (MD 44.4%) have good 
gene transfection efficiency in cell lines of COS7, Hela and MDA-MB-231.   
Chapter 5: Functionalization of Lignin through ATRP Grafting of Poly[(2-




[1] Boerjan W, Ralph J, Baucher M. Lignin biosynthesis. Annu Rev Plant Biol. 
2003;54:519-46. 
[2] Gosselink RJA, de Jong E, Guran B, Abacherli A. Co-ordination network for 
lignin - standardisation, production and applications adapted to market requirements 
(EUROLIGNIN). Ind Crop Prod. 2004;20:121-9. 
[3] Binh NTT, Luong ND, Kim DO, Lee SH, Kim BJ, Lee YS, et al. Synthesis of 
Lignin-Based Thermoplastic Copolyester Using Kraft Lignin as a Macromonomer. 
Compos Interfaces. 2009;16:923-35. 
[4] Kadla JF, Kubo S. Miscibility and hydrogen bonding in blends of poly(ethylene 
oxide) and kraft lignin. Macromolecules. 2003;36:7803-11. 
[5] Kubo S, Kadla JF. The formation of strong intermolecular interactions in 
immiscible blends of poly(vinyl alcohol) (PVA) and lignin. Biomacromolecules. 
2003;4:561-7. 
[6] Kubo S, Kadla JF. Poly(ethylene oxide)/organosolv lignin blends: Relationship 
between thermal properties, chemical structure, and blend behavior. Macromolecules. 
2004;37:6904-11. 
[7] Griffith WL, Compere AL. Separation of alcohols from solution by lignin gels. 
Sep Sci Technol. 2008;43:2396-405. 
[8] Li J, Lu Y, Yang D, Sun Q, Liu Y, Zhao H. Lignocellulose aerogel from wood-
ionic liquid solution (1-allyl-3-methylimidazolium chloride) under freezing and 
thawing conditions. Biomacromolecules. 2011;12:1860-7. 
[9] Uraki Y, Imura T, Kishimoto T, Ubukata M. Body temperature-responsive gels 
derived from hydroxypropylcellulose bearing lignin. Carbohydr Polym. 2004;58:123-
30. 
[10] Matyjaszewski K, Xia J. Atom transfer radical polymerization. Chem Rev. 
2001;101:2921-90. 
[11] Davin LB, Lewis NG. Lignin primary structures and dirigent sites. Curr Opin 
Biotechnol. 2005;16:407-15. 
[12] Zhang ZX, Liu KL, Li J. Self-Assembly and Micellization of a Dual 
Thermoresponsive Supramolecular Pseudo-Block Copolymer. Macromolecules. 
2011;44:1182-93. 
[13] Zhang ZX, Liu X, Xu FJ, Loh XJ, Kang ET, Neoh KG, et al. Pseudo-block 
copolymer based on star-shaped poly(N-isopropylacrylamide) with a beta-
cyclodextrin core and guest-bearing PEG: Controlling thermoresponsivity through 
supramolecular self-assembly. Macromolecules. 2008;41:5967-70. 
[14] Tiera MJ, Shi Q, Winnik FM, Fernandes JC. Polycation-based gene therapy: 
current knowledge and new perspectives. Curr Gene Ther. 2011;11:288-306. 
 
Chapter 6: Conclusion and Future Research 
159 
CHAPTER 6 CONCLUSION AND FUTURE 
RESEARCH 
6.1 Summary of Results 
This research made a study on design of functional copolymers based on 
naturally occurring materials, such as cyclodextrin and lignin, and cationic polymers 
(low molecular weight PEI and PDMAEMA), followed by investigating their 
potential applications in biomedical field. Three copolymer systems were developed 
in this work. 
Firstly, a new targeted gene delivery system by conjugating HA with star 
polymer β-CD-OEI through reductive amination between the amine groups of β-CD-
OEI and the hydroxyl groups of HA. Since HA can specifically bind to CD44, which 
is overexpressed on the cell membrane of cancer stem cell, these β-CD-OEI-HA 
polymers showed significantly increased gene transfection efficiency in CD44-
positive  MDA-MA-231 cancer cells comparing with the PEI (25 kDa) and β-CD-
OEI star polymers. In addition, the conjugation of HA onto the β-CD-OEI polymer 
reduced the zeta potential and cytotoxicity of β-CD-OEI-HA/pDNA polyplexes, 
probably due to the negatively charged HA that partially neutralized the OEI arms of 
the cationic polymers. Futhermore, the successful delivery of wild type p53 gene by 
β-CD-OEI-HA polymers in CD44-positive MDA-MB-231 cancer cells resulted in an 
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increased cell cycle arrest at sub-G1 phase, indicating that the β-CD-OEI-HA 
polymers may be promising for efficient cancer gene therapy for the CD44-positive 
subtypes.  
Secondly, a cyclodextrin-based supramolecular hydrogel system with 
supramolecularly anchored active cationic copolymer/plasmid DNA polyplexes was 
explored as a sustained gene delivery carrier. Biodegradable triblock copolymers 
MPEG-PCL-PDMAEMA with well-defined cationic block lengths were prepared to 
condense pDNA. The MPEG-PCL-PDMAEMA copolymers exhibit good ability to 
condense pDNA into 275 - 405 nm nanoparticles with hydrophilic MPEG in the outer 
corona. The MPEG corona imparts greater stability to the DNA polyplexes and also 
serves as anchoring segment when the DNA polyplexes are encapsulated in α-CD 
supramolecular hydrogel. More interestingly, the resultant hydrogels were able to 
sustain in vitro DNA release up to 6 days. The pDNA is released in the form of 
polyplexes as they are bound electrostatically to cationic segment of the copolymers. 
The bioactivity of the released pDNA polyplexes at various durations was further 
investigated. Protein expression level of pDNA polyplexes released over the duration 
is comparable to that of freshly prepared PEI polyplexes. Being thixotropic in nature 
and can be easily prepared without using organic solvent, this supramolecular in-situ 
gelling system has immense potential as an injectable carrier for sustained gene 
delivery.  
Thirdly, a novel cationic copolymer system was developed through 
functionalization of lignin by ATRP grafting of PDMAEMA, and was tested for gene 
transfection. This is the first report in using lignin for gene delivery. These 
copolymers have a hyperbranch structure with a hydrophobic core of lignin and 
multiple cationic hydrophilic arms of PDMAEMA. In vitro gene gelivery experiment 
showed that the gene transfection efficiency of these copolymers is comparable or 
even higher than that of PEI (25 kDa), which is the gold standard. Moreover, their 
 
 
Chapter 6: Conclusion and Future Research 
161 
transfection efficiencies depend greatly on the modification degree (MD) of lignin-
based macroinitiators and the chain length of PDMAEMA arms. 
In short, results of the present study expanded the applications of cationic 
copolymers for gene delivery. This research is helpful to develop new non-viral 
cationic polymers based on biocompatible materials. All the systems mentioned 
above are promising candidates for future cancer gene therapy. 
6.2 Possible Future Research 
  Looking into the future, there are several directions warranting further 
exploration for the application of above supramolecular cationic polymers in gene 
delivery. 
 In the study of the β-CD-OEI-HA, high molecular weight HA (1,000 kDa) 
and low molecular weight HA (< 10 kDa) were analyzed for targeted delivery to 
CD44-positive breast cancer cells. We found that high molecular weight HA was not 
appropriate for further modification due to its huge molecular weight and poor 
solubility, but it still can improve the gene delivery efficiency to CD44-postive breast 
cancer cells. While previous research demonstrated that using high molecular weight 
HA (> 10 kDa) to coat PEI/pDNA resulted in lesser improvements in the stability and 
transfection efficiency of the complexes [1]. A series of cationic polymers with 
different molecular weight of HA should be synthesized and compared for their gene 
delivery efficiency to explore the effect of the HA molecular weight on CD44 
mediated endocytosis.  
Moreover, the cancer stem cell theory has proposed that CD44 represents a 
marker of breast cancer stem cells [2,3]. It may be very important to understand the 
biological behavior of HA and CD44 through real time bioimaging using quantum 
dots (QDots). HA-β-CD-OEI can be further modified by quantum dots (QDots) to 
track the HA mediated endocytosis and select breast cancer stem cell [4]. 
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In addition, as shown in the scope, this thesis focuses on the possibility of 
using these cationic copolymers as non-viral gene delivery vectors through in-vitro 
experiments. It may be of great interest to further investigate their biodistribution, 
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